Ronald L. Ariagno

All Publications

• The culture of research communication in neonatal intensive care units: key stakeholder perspectives. Journal of perinatology : official journal of the California Perinatal Association Degl, J., Ariagno, R., Aschner, J., Beauman, S., Eklund, W., Faro, E., Iwami, H., Jackson, Y., Kenner, C., Kim, I., Klein, A., Short, M., Sorrells, K., Turner, M. A., Ward, R., Winiecki, S., Bucci-Rechtweg, C., International Neonatal Consortium 2021

  Abstract

  OBJECTIVE: To assess the perspectives of neonatologists, neonatal nurses, and parents on research-related education and communication practices in the neonatal intensive care unit (NICU).STUDY DESIGN: Questionnaire circulated through interest groups and administered using the internet.RESULTS: 323 respondents responded to the survey. 52 were neonatologists, 188 were neonatal nurses, and 83 were parents of NICU graduates. Analysis was descriptive. Differences were noted between stakeholder groups with respect to whether current medications meet the needs of sick neonates, research as central to the mission of the NICU, availability of appropriate education/training for all members of the research team, and adequacy of information provided to parents before, during, and after a research study is completed.CONCLUSION: Engagement of nurses and parents at all stages of NICU research is currently suboptimal; relevant good practices, including education, should be shared among neonatal units.

  View details for DOI 10.1038/s41372-021-01220-5

  View details for PubMedID 34663901

• Development of a neonatal adverse event severity scale through a Delphi consensus approach. Archives of disease in childhood Salaets, T. n., Turner, M. A., Short, M. n., Ward, R. M., Hokuto, I. n., Ariagno, R. L., Klein, A. n., Beauman, S. n., Wade, K. n., Thomson, M. n., Roberts, E. n., Harrison, J. n., Quinn, T. n., Baer, G. n., Davis, J. n., Allegaert, K. n. 2019

  Abstract

  Assessment of the seriousness, expectedness and causality are necessary for any adverse event (AE) in a clinical trial. In addition, assessing AE severity helps determine the importance of the AE in the clinical setting. Standardisation of AE severity criteria could make safety information more reliable and comparable across trials. Although standardised AE severity scales have been developed in other research fields, they are not suitable for use in neonates. The development of an AE severity scale to facilitate the conduct and interpretation of neonatal clinical trials is therefore urgently needed.A stepwise consensus process was undertaken within the International Neonatal Consortium (INC) with input from all relevant stakeholders. The consensus process included several rounds of surveys (based on a Delphi approach), face-to-face meetings and a pilot validation.Neonatal AE severity was classified by five grades (mild, moderate, severe, life threatening or death). AE severity in neonates was defined by the effect of the AE on age appropriate behaviour, basal physiological functions and care changes in response to the AE. Pilot validation of the generic criteria revealed κ=0.23 and guided further refinement. This generic scale was applied to 35 typical and common neonatal AEs resulting in the INC neonatal AE severity scale (NAESS) V.1.0, which is now publicly available.The INC NAESS is an ongoing effort that will be continuously updated. Future perspectives include further validation and the development of a training module for users.

  View details for DOI 10.1136/archdischild-2019-317399

  View details for PubMedID 31537552

• A directory for neonatal intensive care: potential for facilitating network-based research in neonatology. Journal of perinatology : official journal of the California Perinatal Association Ariagno, R. L., Lee, H. C., Stevenson, D. K., Benjamin, D. K., Smith, P. B., Escobedo, M. B., Bhatt, D. R. 2018

  Abstract

  Directories of contact information have evolved over time from thick paperback times such as the "Yellow Pages" to electronic forms that are searchable and have other functionalities. In our clinical specialty, the development of a professional directory helped to promote collaboration in clinical care, education, and quality improvement. However, there are opportunities for increasing the utility of the directory by taking advantage of modern web-based tools, and expanding the use of the directory to fill a gap in the area of collaborative research.

  View details for DOI 10.1038/s41372-018-0097-8

  View details for PubMedID 29545621

• The Marshall Klaus Research Award and Tribute to a Trailblazing Neonatologist JOURNAL OF PERINATOLOGY Grossarth, S. N., Coggins, S. A., Tune, A., Ariagno, R. L., Fanaroff, A. A., Weitkamp, J. 2018; 38 (3): 211–16

  View details for PubMedID 29234145

• Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development JOURNAL OF PEDIATRICS Steinhorn, R., Davis, J. M., Gopel, W., Jobe, A., Abman, S., Laughon, M., Bancalari, E., Aschner, J., Ballard, R., Greenough, A., Storari, L., Thomson, M., Ariagno, R. L., Fabbri, L., Turner, M. A., Int Neonatal Consortium 2017; 191: 15-+

  View details for PubMedID 29173299

• Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension JOURNAL OF PERINATOLOGY Sun, H., Stockbridge, N., Ariagno, R. L., Murphy, D., Nelson, R. M., Rodriguez, W. 2016; 36 (12): 1029-1033

  Abstract

  To identify suitable end points and surrogates for pediatric pulmonary arterial hypertension (PAH) as the lack of developmentally appropriate end point and clinical trials contribute to the unmet medical need.Reviewed the efficacy end points and surrogates for all trials (1995 to 2013) that were submitted to the Food and Drug Administration (FDA) to support the approval of PAH therapy and conducted literature search.An increase in the 6 min walking distance (6MWD) was used as a primary end point in 8/9 adult PAH trials. This end point is not suitable for infants and young children because of performance limitations and lack of control data. One adult PAH trial used time to the first morbidity or mortality event as a primary end point, which could potentially be used in pediatric PAH trials. In the sildenafil pediatric PAH trial, the change in pulmonary vascular resistance index or mean pulmonary artery pressure was used as a surrogate for the 6MWD to assess exercise capacity. However, two deaths and three severe adverse events during the catheterizations made this an unacceptably high-risk surrogate. The INOmax persistent pulmonary hypertension of the newborn trial used a reduction in initiation of extracorporeal membrane oxygenation treatment as a primary end point, which is not feasible for other pediatric PAH trials. A Literature review revealed none of the existing noninvasive markers are fully validated as surrogates to assess PAH efficacy and long-term safety.For pediatric PAH trials, clinical end points are acceptable, and novel validated surrogates would be helpful. FDA seeks collaboration with academia, industry and parents to develop other suitable and possibly more efficient efficacy end points to facilitate pediatric PAH drug development.

  View details for DOI 10.1038/jp.2016.103

  View details for PubMedID 27416322

• Inhaled nitric oxide use in preterm infants in California neonatal intensive care units. Journal of perinatology Handley, S. C., Steinhorn, R. H., Hopper, A. O., Govindaswami, B., BHATT, D. R., Van Meurs, K. P., Ariagno, R. L., Gould, J. B., Lee, H. C. 2016; 36 (8): 635-639

  Abstract

  To describe inhaled nitric oxide (iNO) exposure in preterm infants and variation in neonatal intensive care unit (NICU) use.This was a retrospective cohort study of infants, 22 to 33+6/7 weeks of gestational age (GA), during 2005 to 2013. Analyses were stratified by GA and included population characteristics, iNO use over time and hospital variation.Of the 65 824 infants, 1718 (2.61%) received iNO. Infants, 22 to 24+6/7 weeks of GA, had the highest incidence of iNO exposure (6.54%). Community NICUs (n=77, median hospital use rate 0.7%) used less iNO than regional NICUs (n=23, median hospital use rate 5.8%). In 22 to 24+6/7 weeks of GA infants, the median rate in regional centers was 10.6% (hospital interquartile range 3.8% to 22.6%).iNO exposure varied with GA and hospital level, with the most use in extremely premature infants and regional centers. Variation reflects a lack of consensus regarding the appropriate use of iNO for preterm infants.Journal of Perinatology advance online publication, 31 March 2016; doi:10.1038/jp.2016.49.

  View details for DOI 10.1038/jp.2016.49

  View details for PubMedID 27031320

• The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension. NeoReviews Sun, H., Stockbridge, N., Ariagno, R. L., Murphy, D. 2016; 17 (2): e87-e92

  Abstract

  Pulmonary arterial hypertension (PAH) is a rare disease in newborns, infants, and children. It is associated with significant morbidity and mortality, but has limited treatment options. Except for inhaled nitric oxide, which is approved for persistent pulmonary hypertension of the newborn (PPHN), no drug is approved for the treatment of newborns, infants, and children with PAH. The lack of developmentally appropriate pediatric efficacy end points and pediatric clinical trials contribute to this unmet medical need. The noninvasive biomarkers reported in the literature that can be used as potential surrogate end points to assess disease severity and treatment response in neonates, infants, and children with PAH are reviewed herein. In addition, the role of the US Food and Drug Administration in developing potential biomarkers as surrogate end points to facilitate drug development for the treatment of children with PPHN and PAH in children is reviewed herein.

  View details for DOI 10.1542/neo.17-2-e87

  View details for PubMedID 28943808

  View details for PubMedCentralID PMC5609821

• Infant formula and neurocognitive outcomes: impact of study end-point selection. Journal of perinatology Sun, H., Como, P. G., Downey, L. C., Murphy, D., Ariagno, R. L., Rodriguez, W. 2015; 35 (10): 867-874

  View details for DOI 10.1038/jp.2015.87

  View details for PubMedID 26248129

• Philip Sunshine Festschrift: a quintessential neonatologist with wit and humor. Journal of perinatology Ariagno, R. L. 2011; 31: S9-S10

  View details for DOI 10.1038/jp.2010.181

  View details for PubMedID 21448215

• Resting heart rate does not predict growth in preterm infants EARLY HUMAN DEVELOPMENT Ruth, V., Kennedy, C., Rehm, R., Ariagno, R., Lee, K. A. 2010; 86 (1): 23-27

  Abstract

  Previous reports indicate that preterm infants with higher baseline heart rate (HR) have greater weight gain than preterm infants with lower baseline HR. To verify this correlation and the potential utility of resting HR as a bench mark for risk of extrauterine growth restriction (EUGR), we studied preterm infants born between 32 and 36weeks gestation. Earlier gestation infants (27 to 31weeks) were included.In retrospective chart review we collected heart rate (HR) and growth data on 156 infants between 27.0 and 34.0weeks gestation from birth to hospital discharge.There was a significant increase in weight gain from day 10 of life in infants with higher resting HR compared to infants with lower resting HR. However, upon controlling for birth weight and gestational age, there was no significant relationship between HR and weight gain for any gestational age group of premature infants.Contrary to previous reports, there was no significant relationship between HR and growth at any gestational age after controlling for birth weight and gestational age. It is important to continue to search for a clinical marker of risk for poor growth in preterm infants and to give an opportunity for nutritional interventions which may support better growth and developmental outcomes.

  View details for DOI 10.1016/j.earlhumdev.2009.12.005

  View details for Web of Science ID 000275597100005

  View details for PubMedID 20089373

• Can magnetic resonance spectroscopy predict neurodevelopmental outcome in very low birth weight preterm infants? Annual Meeting of the Pediatric-Academic-Societies/Society-of-Pediatric-Research Augustine, E. M., Spielman, D. M., Barnes, P. D., Sutcliffe, T. L., Dermon, J. D., Mirmiran, M., Clayton, D. B., Ariagno, R. L. NATURE PUBLISHING GROUP. 2008: 611–18

  Abstract

  To determine if metabolite ratios at near-term age predict outcome in very low birth weight preterm infants at 18 to 24 months adjusted age.Thirty-six infants (birth weight

  View details for DOI 10.1038/jp.2008.66

  View details for Web of Science ID 000258990600005

  View details for PubMedID 18615089

  View details for PubMedCentralID PMC2844764

• The late preterm infant and the control of breathing, sleep, and brainstem development: A review CLINICS IN PERINATOLOGY Darnall, R. A., Ariagno, R. L., Kinney, H. C. 2006; 33 (4): 883-?

  Abstract

  The brainstem development of infants born between 33 and 38 weeks' gestation is less mature than that of a full-term infant. During late gestation, there are dramatic and nonlinear developmental changes in the brainstem. This translates into immaturity of upper airway and lung volume control, laryngeal reflexes, chemical control of breathing, and sleep mechanisms. Ten percent of late preterm infants have significant apnea of prematurity and they frequently have delays in establishing coordination of feeding and breathing. Unfortunately, there is a paucity of clinical, physiologic, neuroanatomic, and neurochemical data in this specific group of infants. Research focused on this group of infants will not only further our understanding of brainstem maturation during this high risk period, but will help develop focused plans for their management.

  View details for DOI 10.1016/j.clp.2006.10.004

  View details for Web of Science ID 000243140500011

  View details for PubMedID 17148011

• Survey of neonatology training programs: 2002 to 2003 JOURNAL OF PERINATOLOGY Ariagno, R. L. 2006; 26: S38-S45

  Abstract

  The Committee on Research in Neonatology from the Section on Perinatal Pediatrics, American Academy of Pediatrics presents an overview of the update of the Neonatal-Perinatal Training Program Survey obtained in 2002 to 2003. Our goal was to update the last survey in 1996 and to begin to assess research resources and the potential for training life-career physician scientists (basic and clinical investigators).

  View details for DOI 10.1038/sj.jp.7211521

  View details for Web of Science ID 000241844600010

  View details for PubMedID 16801968

• National Institute of Child Health and Human Development (NICHD) and American Academy of Pediatrics (AAP) workshop on research in neonatal and perinatal medicine JOURNAL OF PERINATOLOGY Ariagno, R. L. 2006; 26: S3-S4

  View details for DOI 10.1038/sj.jp.7211425

  View details for Web of Science ID 000241844600002

  View details for PubMedID 16801965

• Fewer spontaneous arousals during prone sleep in preterm infants at 1 and 3 months corrected age JOURNAL OF PERINATOLOGY Ariagno, R. L., van Liempt, S., Mirmiran, M. 2006; 26 (5): 306-312

  Abstract

  This study was performed to determine if there were fewer spontaneous arousals in prone sleep than in supine sleep.Home polysomnography/video recordings were done during daytime naps in 14 preterm infants: four at corrected age of 1 month, nine at both 1 and 3 months, and one only at 3 month. A body movement lasting 3 to 60 s during sleep was used as an indicator of spontaneous arousals.Most arousals had a heart rate increase and change in respiration pattern. The mean duration of the intervals between successive arousals in active and quiet sleep was significantly longer in prone at 1 and 3 months of age. The duration of arousals was significantly shorter at 3 months corrected age compared with one month corrected age during active sleep. The duration of arousals was shorter during quiet sleep at one month compared with active sleep.There were fewer spontaneous arousals that is, longer interval between successive arousals in prone, which may, in part, explain the increase in risk of Sudden Infant Death Syndrome.

  View details for DOI 10.1038/sj.jp.7211490

  View details for Web of Science ID 000241843700010

  View details for PubMedID 16572196

• Metabolite ratios measured by proton magnetic resonance spectroscopy correlate with postmenstrual age in very low birth weight preterm infants with normal neuromotor and Bayley results. Western Regional Meeting of the American-Federation-for-Medical-Research Van Brussel, E. M., Mirmiran, M., Spielman, D. M., Barnes, P. D., Sutcliffe, T. L., Dermon, J. D., Ariagno, R. L. LIPPINCOTT WILLIAMS & WILKINS. 2006: S97–S97

  View details for Web of Science ID 000235301500117

• Neonatology Research for the 21st Century: Executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics Workshop. Part II: Training issues PEDIATRICS Ariagno, R. L., van Marter, L. J., Higgins, R., Raju, T. N. 2005; 115 (2): 475-479

  Abstract

  This is the second part of the executive summary based on the presentations and discussions at a workshop on research in neonatology sponsored by the National Institute of Child Health and Human Development and the American Academy of Pediatrics held in January 2004. In this article, neonatology fellowship training requirements and workforce issues are addressed, and the reasons for the shortage of physician-scientists, particularly of the underrepresented minority ethnic groups, are highlighted. Full-length articles from the presented topics are yet to be published.

  View details for DOI 10.1542/peds.2004-2559

  View details for Web of Science ID 000226725000048

  View details for PubMedID 15687458

• Research in Neonatology for the 21st Century: Executive summary of the National Institute of Child Health and Human Development-American Academy of Pediatrics Workshop. Part I: Academic issues PEDIATRICS Raju, T. N., Ariagno, R. L., Higgins, R., van Marter, L. J. 2005; 115 (2): 468-474

  Abstract

  This article presents the executive summary of the presentations and discussions at the Workshop on Research in Neonatology sponsored by the National Institute of Child Health and Human Development and the American Academy of Pediatrics Section on Perinatal Pediatrics convened in January 2004. In this article, the scientific aspects are summarized, highlighting the current knowledge gaps and identifying research priorities with a focus on emerging technologies. In a separate article, issues concerning workforce needs and shortages and board-certification requirements are presented. Full-length articles on the presented topics will be published in the Journal of Perinatology.

  View details for DOI 10.1542/peds.2004-2556

  View details for Web of Science ID 000226725000047

  View details for PubMedID 15687457

• Internal capsule abnormalities on neonatal brain MRI are associated with later gait disorders in very low birth weight preterm children at 4 years. Rose, J., Mirmiran, M., Butler, E. E., Lin, C., Barnes, P. D., Kermoian, R., Stevenson, D. K., Ariagno, R. L. LIPPINCOTT WILLIAMS & WILKINS. 2005: S126–S126

  View details for Web of Science ID 000226539700286

• Neonatal brain magnetic resonance imaging before discharge is better than serial cranial ultrasound in predicting cerebral palsy in very low birth weight preterm infants PEDIATRICS Mirmiran, M., Barnes, P. D., Keller, K., Constantinou, J. C., Fleisher, B. E., Hintz, S. R., Ariagno, R. L. 2004; 114 (4): 992-998

  Abstract

  To compare the value of serial cranial ultrasound (US) with a single magnetic resonance imaging (MRI) before discharge in very low birth weight preterm infants to predict cerebral palsy (CP).Infants who weighed <1250 g at birth and were <30 weeks' gestational age underwent conventional brain MRI at near term (36-40 weeks' postmenstrual age) using 1.5 Tesla MRI scanner. Sagittal and axial T1 and T2 fluid attenuated inversion recovery and gradient recalled echo images were obtained. Cranial US was also obtained at least twice during the first 2 weeks of life. MRI and US images were interpreted by 2 independent radiologists, who were masked to clinical outcome, and scored as follows: category 1, no abnormality; category 2, subependymal hemorrhage or mineralization; category 3, moderate to severe ventriculomegaly; category 4, focal parenchymal abnormality with or without ventriculomegaly. For the purpose of this study, 1 and 2 were categorized as "normal," and 3 and 4 were categorized as "abnormal." The infants were assessed at a mean age of 20 and 31 months using the Amiel-Tison standardized neurodevelopmental examination.The sensitivity and specificity of MRI for predicting CP were 71% and 91% at 20 month and 86% and 89% at 31 months, respectively. The sensitivity and specificity of US for predicting CP were 29% and 86% at 20 months and 43% and 82% at 31 months.As a predictor of outcome for CP, MRI at near-term in very low birth weight preterm neonates is superior to US. However, both US and MRI demonstrate high specificity.

  View details for DOI 10.1542/peds.2003-0772-L

  View details for Web of Science ID 000224242200034

  View details for PubMedID 15466096

• Spontaneous kicking patterns at 3 months corrected age in preterm infants with normal and abnormal neonatal brain MRI Annual Meeting of the Pediatric-Academic-Societies Butler, E. F., Smith, D., Gaman, S. K., Rose, J., Mirmiran, M., Barnes, P. D., Ariagno, R. L. NATURE PUBLISHING GROUP. 2004: 413A–413A

  View details for Web of Science ID 000220591102412

• Diffusion tensor brain imaging findings at term-equivalent age may predict neurologic abnormalities in low birth weight preterm infants AMERICAN JOURNAL OF NEURORADIOLOGY Arzoumanian, Y., Mirmiran, M., Barnes, P. D., Woolley, K., Ariagno, R. L., Moseley, M. E., Fleisher, B. E., Atlas, S. W. 2003; 24 (8): 1646-1653

  Abstract

  Low birth weight preterm infants are at high risk of brain injury, particularly injury to the white matter. Diffusion tensor imaging is thought to be more sensitive than conventional MR imaging for detecting subtle white matter abnormalities. The objective of this study was to examine whether diffusion tensor imaging could detect abnormalities that may be associated with later neurologic abnormalities in infants with otherwise normal or minimally abnormal conventional MR imaging findings.We prospectively studied 137 low birth weight (<1800 g) preterm infants. Neonatal conventional MR imaging and diffusion tensor imaging were performed near term-equivalent age before discharge, and neurologic development of the infants was later followed up at 18 to 24 months of age.Among the preterm infants who were fully studied, 63 underwent normal conventional MR imaging. Three of these infants developed cerebral palsy, and 10 others showed abnormal neurologic outcome. Diffusion tensor imaging results for these infants showed a significant reduction of fractional anisotropy in the posterior limb of the internal capsule in neurologically abnormal infants (including those with cerebral palsy) compared with control preterm infants with normal neurologic outcomes.These results suggest that neonatal diffusion tensor imaging may allow earlier detection of specific anatomic findings of microstructural abnormalities in infants at risk for neurologic abnormalities and disability. The combination of conventional MR imaging and diffusion tensor imaging may increase the predictive value of neonatal MR imaging for later neurologic outcome abnormalities and may become the basis for future interventional clinical studies to improve outcomes.

  View details for Web of Science ID 000185400100031

  View details for PubMedID 13679287

• Development of fetal and neonatal sleep and circadian rhythms SLEEP MEDICINE REVIEWS Mirmiran, M., Maas, Y. G., Ariagno, R. L. 2003; 7 (4): 321-334

  Abstract

  The origin of sleep and circadian rhythms development is found during the fetal period. Both quiet (NREM) and active (REM) sleep are distinguishable during the last 10 weeks of gestation. Comparable to fetuses, low risk preterm infants recorded at 30-40 weeks postconceptional age, had a similar development of sleep i.e. an increase in quiet sleep and a decrease in indeterminate sleep. A further development in sleep organization characterized by increased slow wave and spindle activity during quiet sleep and coupling with circadian rhythm takes place during the first 6 months of life in both term and preterm infants.Circadian rhythm of fetal heart rate synchronized with maternal rest-activity, heart rate, cortisol, melatonin, and body temperature rhythms is present during the last 10 weeks of gestation. Although maternally influenced, circadian rhythm antenatally becomes ultradian at birth. Both preterm and term infants show a significant increase in circadian body temperature rhythm amplitude during the first 3 months of life.

  View details for DOI 10.1053/smrv.2002.0243

  View details for Web of Science ID 000184673200006

  View details for PubMedID 14505599

• Circadian and sleep development in preterm infants occurs independently from the influences of environmental lighting PEDIATRIC RESEARCH Mirmiran, M., Baldwin, R. B., Ariagno, R. L. 2003; 53 (6): 933-938

  Abstract

  This study investigated the effect of intermediate nursery illumination on circadian rhythm and sleep development of preterm infants. Preterm infants were randomly assigned to one of two intermediate nursery rooms: a dimly lighted room, the dim (control) group, or a day-night lighted room, the cycled (intervention) group. Continuous rectal temperature and sleep were recorded at 36 wk postconceptional age (before discharge) and at 1 and 3 mo corrected age at home. Forty infants, 21 in the dim group and 19 in the cycled group, were recorded. The clinical demographic data and neonatal scores were similar between groups before the intervention. Circadian rhythms and sleep showed significant development with age, but there was no environmental lighting effect. Circadian and sleep organization seems to develop endogenously in preterm infants.

  View details for DOI 10.1203/01.PDR.0000061541.94620.12

  View details for Web of Science ID 000183288600012

  View details for PubMedID 12621096

• Abnormal fetal heart rate tracings do not correlate with MRI and neurologic outcome in preterm infants Annual Meeting of the Pediatric-Academic-Societies/Society-for-Pediatric-Research Gupta, S., Mirmiran, M., Ariagno, R. L., Lyell, D., Druzin, M. NATURE PUBLISHING GROUP. 2003: 543A–544A

  View details for Web of Science ID 000181897903072

• Effect of position on sleep, heart rate variability, and QT interval in preterm infants at 1 and 3 months' corrected age PEDIATRICS Ariagno, R. L., Mirmiran, M., Adams, M. M., Saporito, A. G., Dubin, A. M., Baldwin, R. B. 2003; 111 (3): 622-625

  Abstract

  Prone sleeping position has a strong link to sudden infant death syndrome (SIDS), and the "Back to Sleep" campaign has played an important role in reducing SIDS. We tested the hypothesis that the mechanism of the sleep position effect is based on changes in sleep, arousal, heart rate variability (HRV), and the QT interval of the electrocardiogram.We studied 16 premature infants longitudinally, at 1 and 3 months' corrected age. Videosomnography recordings were made during the infants' normal daytime naps. Each infant was recorded in both supine and prone positions. The recordings were analyzed in 30-second epochs, which were classified as awake, active sleep (AS), quiet sleep (QS), or indeterminate sleep. Electrocardiogram data were sampled with an accuracy of 1 millisecond. Time domain analysis of HRV was measured by standard deviation of all R-R intervals and by the square root of the mean of the sum of the squares of the differences between adjacent R-R intervals. Frequency domain analysis was done for low frequency (0.04-0.14 Hz) and high frequency (0.15-0.5 Hz) HRV. We measured QT, JT, and R-R intervals during AS and QS for each position.We found no significant differences between supine and prone position, either in total sleep time or in percentage of QS. Percentage of AS was significantly lower in the supine position, but only at 1 month corrected age. The incidence of short, spontaneous, sleep transitions was significantly higher in supine, also only at 1 month corrected age. Time domain analysis of HRV showed a significantly lower variability in prone, but only during QS. Frequency domain analysis of HRV showed no differences between the 2 sleeping positions. Both QT and JT intervals were significantly longer in prone during QS, but only at 1 month corrected age.Despite the commonly held belief, prone position did not substantially increase total sleep at these ages. On the other hand, prone sleeping decreased the number of sleep transitions at 1 month corrected age, increased QT and JT intervals, and reduced HRV, thereby potentially increasing the vulnerability for SIDS. This study supports "Back to Sleep" as the position of choice not only for term but also for preterm infants after discharge home.

  View details for Web of Science ID 000181294000044

  View details for PubMedID 12612246

• Candida (amphotericin-sensitive) lens abscess associated with decreasing arterial blood flow in a very low birth weight preterm infant PEDIATRICS Drohan, L., Colby, C. E., Brindle, M. E., Sanislo, S., Ariagno, R. L. 2002; 110 (5)

  Abstract

  In this report, we review the case of a candidal lens abscess in a premature infant girl who was 28 weeks' gestational age at birth. The culture obtained from the lens abscess grew Candida albicans sensitive to amphotericin B but resistant to flucytosine. This case is unique in that the infant developed a fungal lens cataract at 34 weeks' postconceptional age during the last week of a 30-day course of amphotericin B. The embryonic hyaloid artery system, which perfuses the developing lens, regresses between 29 and 32 weeks of gestation; thus, the mechanism for an infection of the lens may be inoculation of the lens by Candida before hyaloid artery system regression, followed by developmental loss of this blood supply, which makes the lens inaccessible to antimicrobial penetration. Candidal endophthalmitis with lens abscess is an uncommon morbidity that requires prompt recognition and surgical intervention for effective management.

  View details for PubMedID 12415071

• The influence of sleep state and sleep position on spontaneous arousal in healthy preterm infants at 1 and 3 months corrected age Ariagno, R. L., Mirmiran, M., van Leimpt, S., Adams, M. M. NATURE PUBLISHING GROUP. 2002: 377A–378A

  View details for Web of Science ID 000174714602195

• Cisapride associated with QTc prolongation in very low birth weight preterm infants PEDIATRICS Dubin, A., Kikkert, M., Mirmiran, M., Ariagno, R. 2001; 107 (6): 1313-1316

  Abstract

  No systematic study has been performed to evaluate the effect of cisapride on the QT interval in premature infants. Cisapride, which has recently been withdrawn by the Food and Drug Administration and is no longer an approved therapy, was commonly used for preterm infant care to improve the advance of enteral feedings and to reduce reflux and associated apnea. Our aim was to evaluate the effect of recommended doses of cisapride on the QT interval in this population.Prospective blinded evaluation of electrocardiogram for QT, JT, QTc, and JTc measurements in 25 preterm infants before and after cisapride administration.Twelve of 25 infants (48%) developed repolarization abnormalities with cisapride administration: 32% of the infants (8/25) studied had QTc prolongation (>/=0.450 seconds), whereas 10/25 had JTc prolongation (>/=0.360 seconds). Preterm infants <32 weeks significantly prolonged their QTc interval from 0.41 +/- 0.02 to 0.44 +/- 0.02. The QTc and/or JTc was prolonged in 54% of infants receiving 0.1 mg/kg/dose and 42% receiving 0.2 mg/kg/dose.The QTc and JTc interval significantly prolonged in preterm infants <32 weeks on the recommended dose of cisapride therapy. A QTc >/=0.450 seconds developed in 32% of infants treated with cisapride, whereas the JTc prolonged in 40%. A significant percentage of infants (54%) developed prolonged QTc intervals at a dose of 0.1 mg/kg/dose. From these data we conclude that there is a higher risk of prolongation of the QTc interval and risk of arrhythmias with greater prematurity.

  View details for Web of Science ID 000169105500034

  View details for PubMedID 11389249

• Cisapride decreases gastroesophageal reflux in preterm infants PEDIATRICS Ariagno, R. L., Kikkert, M. A., Mirmiran, M., Conrad, C., Baldwin, R. B. 2001; 107 (4)

  Abstract

  Gastrointestinal prokinetic agents, such as cisapride, are commonly used in pediatric practice to improve gastric emptying, to decrease emesis, to improve lower esophageal sphincter tone, and to improve irritability and feeding aversion associated with gastroesophageal reflux (GER). Although cisapride seems to be effective in infants from 2 months to 14 years old, data for younger and preterm infants are not available. Whether reflux is a significant cause of reflex apnea or feeding intolerance in the preterm infant is controversial. The objective of this 1-year prospective study, started in 1998, was to determine the efficacy of cisapride for treatment of reflux and reflux-associated apnea (RAAP) in preterm infants. Before this study, the diagnosis of reflux was often made clinically and the effect of therapy on reflux or the decision to increase the dose of cisapride was made empirically. The clinical bias was that persistent apnea, not responding to caffeine, was caused by GER. We reasoned that a systematic approach to the diagnosis and treatment of reflux would improve the care of preterm infants and reduce the risk of toxicity, especially if an increased dose of cisapride showed no improvement in reflux or apnea.Twenty-four preterm infants (24-36 weeks' gestational age) had clinical apnea/pH studies when they were referred by the attending neonatologist for suspected GER. These infants were born at 28.8 +/- 3.1 weeks with birth weight of 1169 +/- 387 g (range: 631-2263 g). Each infant was studied before and 8 days after starting cisapride treatment. Cisapride dose was 0.09 to 0.25 mg/kg every 6 hours enterally. Treatment decisions regarding dose of cisapride were the responsibility of the attending neonatologist. The pH was recorded continuously for 24 hours at 0.25 Hz and was analyzed using EsopHogram software. A single sensor pH catheter was inserted to ~2 cm above the esophageal gastric junction. GER was defined as a drop in esophageal pH below 4.0 for a least 5 seconds, or pathologic GER was defined as a reflux index (RI) >2 standard deviation (SD) from the mean based on published norms for term infants. The following parameters were calculated from the pH recording: number of reflux events per 24 hours, duration of the longest episode, number of episodes >5 minutes per 24 hours, and RI, ie, percentage of time with pH <4.0. Each study had a combined time-lapse video recording and multichannel digital recording. Recorded parameters were: continuous pulse oximetry, electrocardiogram, respiratory effort (piezo sensor), and airflow (temperature sensor at nostrils and mouth). The recording was scored for central apneas of 10 to 14 seconds and >/=15 seconds (prolonged) and >/=10 seconds for obstructive and mixed apneas. RAAP was scored when an apnea (irrespective of the type) occurred within 1 minute of a GER event. Baseline, after cisapride, and follow-up electrocardiograms were performed because of concern about prolonged QTc and cardiac arrhythmias. The infants were 35.6 +/- 4.5 weeks postconceptional age when first studied. Twelve infants (mean birth weight: 1821 +/- 749 g; gestational age: 32 +/- 2 weeks; postconceptional age: 35.6 +/- 2.6 weeks) were identified retrospectively as controls because their baseline GER parameters were within the normal range using Vandenplas' criteria.Overall, cisapride treatment significantly improved the RI from 16.6 +/- 15.2 to 9.1 +/- 8.4 SD. The number of reflux episodes >/=5 minutes was reduced from 7.1 +/- 5.8 to 4.3 +/- 4.4 SD. No significant effect was seen on the total number of refluxes (/24 hours). Eight infants (33%) had no decrease in the RI after a week of treatment. Three of these infants improved after cisapride dose was increased from 0.09 to 0.25 mg/kg/dose every 6 hours. Although 0.09 mg/kg/day is the minimum effective dose, 67% of our infants did respond to this low dose. Cisapride was discontinued in 3 infants because of prolonged QTc >/=0.450 seconds (0.473 in 1 and 0.470 in 2). More data about the effect of cisapride on QTc interval are reported in Pediatrics in a separate article. Only 1 infant showed no improvement with increased dose. Caffeine treatment had no effect on the baseline or follow-up GER values. Although apnea indexes for central and obstructive apnea were similar before and after cisapride, mixed apnea was less during treatment. There was a significant decrease (0.32 +/- 0.40 to 0.12 +/- 0.17/hour) in RAAP when the one infant who had increased reflux on increased dose of cisapride was excluded as an outlier. The statistical difference, before and after cisapride, for the group is significant with the outlier omitted. The clinical significance is unclear because ~50% of the infants had minimal changes in their apnea indexes. Furthermore, ~40% of infants did not have RAAP. (ABSTRACT TRUNCATED)

  View details for Web of Science ID 000168116200015

  View details for PubMedID 11335779

• Influence of light in the NICU on the development of circadian rhythms in preterm infants SEMINARS IN PERINATOLOGY Mirmiran, M., Ariagno, R. L. 2000; 24 (4): 247-257

  Abstract

  The fetal biological clock is an endogenous clock capable of generating circadian rhythms and responding to maternal entraining signals. By at least the third trimester of pregnancy fetal diurnal rhythms are entrainable by maternal day-night rhythms. Maternal illness during pregnancy and premature birth are obvious clinical factors that may adversely affect circadian rhythm development. Premature birth of the fetus has a most dramatic impact on maternal fetal interactions. The effect on biorhythms appears to be temporary and is greatest on the most immature infants. The results to date support the importance of fetal circadian rhythms and the relative lack of these rhythms in the preterm infant. It is well known that growth and development in the prematurely born infant are influenced by a multitude of factors; clearly, the neonatal intensive care unit is not a surrogate for the maternal placental unit. This article reviews what is known about circadian development in the human infant with an emphasis on the unique circumstances of the preterm infant. The research on the short- and long-term effects of environmental interventions on circadian, sleep, and neurologic development is discussed. Although an earlier onset of circadian development did not result with cycled lighting in the neonatal nursery, there may still be important biological effects that have not been studied. There are sufficient data to state that there is no reason for continuing a chaotic, noncircadian environmental approach for the care of the prematurely born infant.

  View details for Web of Science ID 000089255700004

  View details for PubMedID 10975431

• Predictive value of neonatal neurological tests for developmental outcome of preterm infants JOURNAL OF PEDIATRICS Maas, Y. G., Mirmiran, M., Hart, A. A., Koppe, J. G., Ariagno, R. L., Spekreijse, H. 2000; 137 (1): 100-106

  Abstract

  There is a need to identify, as early as possible, infants who are at risk for long-term neurological morbidity.To predict neurodevelopment outcome of preterm infants <30 weeks' gestation in a population of 100 infants, we used several neonatal and neurobehavioral tests, including cranial ultrasonography, the Prechtl neurological test, quality of spontaneous general movements, and quality of sleep-wake organization.The Prechtl test at corrected term age and findings on cranial sonograms both had high specificity, but the Prechtl test had better overall positive predictive power for normal neurological and developmental outcomes at 2 years' corrected age. Developmental changes in sleep and the amount of indeterminate sleep did not correlate with outcome. Scoring general movement quality did not predict outcome and did not augment the positive predictive power of the Prechtl test.The Prechtl test at corrected term age (independent of the other tests) is the best positive predictor of normal neurological outcome and Bayley test results at 2 years' corrected age.

  View details for DOI 10.1067/mpd.2000.106901

  View details for Web of Science ID 000088204000021

  View details for PubMedID 10891830

• Influence of prone-supine position on sleep and heart rate variability in preterm infants at one month corrected age Adams, M., Mirmiran, M., Dubin, A., Boeddiker, M., Baldwin, R., Ariagno, R. NATURE PUBLISHING GROUP. 2000: 383A–383A

  View details for Web of Science ID 000086155302260

• Effects of prone and supine position on sleep in preterm infants at one month corrected age Adams, M., Mirmiran, M., Boeddiker, M., Baldwin, R. B., Ariagno, R. L. NATURE PUBLISHING GROUP. 1999: 180A–180A

  View details for Web of Science ID 000079476701053

• Effects of prone and supine sleeping position on heart rate variability in preterm infants Goto, K., Mirmiran, M., Adams, M., Boeddiker, M., Baldwin, R. B., Chiang, A., Ariagno, R. L. NATURE PUBLISHING GROUP. 1999: 199A–199A

  View details for Web of Science ID 000079476701169

• Effects of prone and supine position on sleep characteristics in preterm infants PSYCHIATRY AND CLINICAL NEUROSCIENCES Goto, K., Maeda, T., Mirmiran, M., Ariagno, R. 1999; 53 (2): 315-317

  Abstract

  The purpose of this study was to address the influence of sleep position on sleep characteristics in preterm infants. We studied 16 infants at a mean post-conceptional age of 36.5 weeks. Infants were successfully recorded with videopolysomnograph in the supine and prone position. Between the two positions, there were no significant differences in percentage of active sleep and quiet sleep (QS), the occurrence of arousal, and the incidence of apnea. The first QS after the feeding was longer in the prone position. The sleep position could affect sleep characteristics but not respiratory characteristics in preterm infants.

  View details for Web of Science ID 000081146200062

  View details for PubMedID 10459722

• More awakenings and heart rate variability during supine sleep in preterm infants PEDIATRICS Goto, K., Mirmiran, M., Adams, M. M., Longford, R. V., Baldwin, R. B., Boeddiker, M. A., Ariagno, R. L. 1999; 103 (3): 603-609

  Abstract

  The Task Force of The American Academy of Pediatrics (1996) recommends the nonprone sleeping position for asymptomatic preterm infants to prevent sudden infant death syndrome. The mechanism by which the nonprone sleeping position reduces the rate of sudden infant death syndrome is unclear for full-term infants and the precise effect of sleeping position on sleep and cardiorespiratory characteristics has never been addressed in preterm infants. The purpose of the present study was to clarify the effect of sleeping position on sleep and cardiorespiratory characteristics in preterm infants at an age when they are ready for discharge.Sixteen asymptomatic preterm infants were studied in both supine and prone sleeping positions at 36.5 +/- 0.6 weeks' postconceptional age using videosomnography. Sleep, respiratory, and heart rate characteristics were compared between the two positions using each infant as his/her own control.More awakenings (ie, arousals >/=60 seconds) were seen during all sleep states in the supine sleeping position but overall the total sleep and percent sleep state were not affected by sleeping position. After each feeding, the first quiet sleep was significantly shorter, with more heart rate variability and awakenings in the supine position. There were no significant differences in the occurrence of arousals (<60 seconds) or the incidence or severity of apnea and periodic breathing. No clinically significant apnea (>/=15 seconds), bradycardia, or oxygen desaturations were seen.In 36-week-postconceptional age preterm infants, the supine sleeping position had less quiet sleep and was associated with greater heart rate variability during the first sleep cycle after the feeding. More awakenings were seen during all sleep states in the supine position. These data support the American Academy of Pediatrics recommendation for "Back to Sleep" for asymptomatic preterm infants because more awakenings and lower threshold for arousal may provide some benefit for the infant responding to a life-threatening event. However, further studies are needed to address positional effect on the physiologic measures in preterm infants at older ages (later stages of development). Precisely what constitutes the most healthy or advantageous sleep for newborn infants remains an important question.

  View details for Web of Science ID 000078960100012

  View details for PubMedID 10049964

• Effects of prone or supine position on sleep in preterm infants at one month corrected age. Adams, M. M., Mirmiran, M., Boeddiker, M. A., Baldwin, R. B., Ariagno, R. L. LIPPINCOTT WILLIAMS & WILKINS. 1999: 57A–57A

  View details for Web of Science ID 000078137600301

• Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants PEDIATRICS Null, D., Bimle, C., Weisman, L., Johnson, K., Steichen, J., Singh, S., Wang, E., Asztalos, E., Loeffler, A. M., Azimi, P. H., Lieberman, J. M., O'Donnell, N. E., Cooke, R. J., McCormick, K., Koo, W., Hammami, M., Milner, A. D., Gaon, P., Nachman, S., Tarpey, K. P., Sanchez, P. J., Broyles, R. S., Bratcher, D., Ball, M. V., Duda, F. J., DeCuir, P. M., Pollara, B., Nelson, L. S., Balbus, M., Schultz, M. J., Chipps, B. E., Givner, L. B., O'Shea, M., Everard, M., Pfeffer, K., Page, A. J., Dennehy, P. H., Modlin, J., Rhodes, T., DeVincenzo, N., Nickerson, B., Arrieta, A., Boucher, F. D., Keeney, R. E., Young, T. E., Stevens, J. C., Ariagno, R., Adams, M., Polak, M. J., Lynch, S. K., Gerdes, J. S., Kuba, M., Aouthmany, M., Lamar, K., Chang, G. Y., Shelton, M. M., Hadeed, S. K., Vasan, U., Hennessy, A., YOGEV, R., Welliver, R. C., Tristram, D., Albin, C., Jefferson, T. T., Purdy, G. D., Buckner, C. M., Schlessel, J., Sia, C., Tan, B., Sankaran, K., Morley, C. J., White, D. K., Meissner, H. C., Frantz, I., Desai, S. A., Stanley, C. W., Inwood, R., Solecki, L. E., Wald, E., Smail, K., Fox, R. E., Taciak, V., Park, C. L., Vidyasagar, D., Redding, G., Mayock, D. E., Reuman, P. D., Bifano, E. M., Estrada, B., Mancao, M. Y., Hook, B., McDavid, G., Rowen, J. L., Patel, J. A., Robinson, J., Lee, B., Rodriguez, W., Arrobio, J., Hocker, J. R., McConnell, C., Piedimonte, G., Sosenko, I., Patel, B., Shervinski, S., Stobie, P. E., Perea, K., Chartrand, S. A., Wilson, M. C., de Lemos, R., Ramanathan, R., Barnett, B. A., Luber, S. R., Raszka, W. V., Holsclaw, D. S., Klein, D. L., Law, B. J., Balsan, M. J., Douglass, B. H., O'Sullivan, B. P., Spaulding, R., Van Dyke, R. B., Merza, A., Hendley, J. O., Boyle, R. J., Hughes, P. A., Horgan, M. J., Maynard, R. C., Teufert, K., Majure, M., George, J. A., Kuerschner, D. R., Ghai, V., Thomas, D., MacDonald, N., Kovesi, T., Blayney, M., Mani, C. S., San Joaquin, V. H., Roberts, L., Wiznia, A., Rosenberg, M., Karna, P., Murray, D. L., Lenney, W., Clayton, S., Oelberg, D. G., Reininger, M. M., Eppes, S. C., Childs, J. A., Gruber, W. C., Hazinski, T. R., Steinberg, E. A., Lopez, L. C., Elliott, G. R., Groothuis, J. R., Simoes, E. E., Hakim, A., Mimouni, F., Rubin, L., Sood, S. K., Sadiq, H. F., Marshall, T. G., Miller, D., Drayton, M. R., O'Neill, S., Chetcuti, P., Trupp, D. L., Heart, J., Cooper, E. R., Brown, E. R., Chetty, A., Rice, T. B., Rupar, D., Cho, C. T., Leff, R. D., Levine, S. D., Kolls, J. K., Hall, M., Smith, S. L., Schwartz, L., Lemen, R. J., Hall, C. B., Long, C. E., Panitch, H., Kolb, S. M., Colombo, J. L., Judy, C. G., Golembe, B. L., Anderson, J. D., McDonald, J., Mccormack, D., Ruggerie, D. P., Triplett, C., Odom, M. W., Lopez-Cox, G., Sawyer, M. H., Connor, J. D., Fergie, J. E., Purcell, K., Kantak, A. D., Fihe, D. M., Davies, H. D., Mitchell, L., Subramanian, K. N., Smith, Y., St John, E. B., Stolz, J. W., Sheils, C., Cox, F., Foshee, W., Diaz, R., Coonce, S., Keyserling, H. L., Padrick, C. B., Lamprecht, C., Livingston, F. R., Langley, J. M., Weller, P., Cropp, G. J., Sola, A., Kumar, M. L., Lapin, C. D., Carlisle, P., Martz, R., Radetsky, M., Midani, S., Rathore, M. H., Riff, E. J., Shay, G. F., Hogvall, E., Russell, D. W., Thomson, A. H., Lawrey, S. M., Hardy, K., Harvey, K., Turner, R., Cox, E. O., Dana, A., Madan, A., Wallace, J., Stevens, D. C., Asmar, B., Selewski, N. A., Kelly, J., Klerr, T., Spruill, S., Conner, E. M., Carlin, D., Top, F. H. 1998; 102 (3): 531-537

  View details for Web of Science ID 000075766800001

• Survey of sleeping position after hospital discharge in healthy preterm infants. Journal of perinatology Adams, M. M., Kugener, B., Mirmiran, M., Ariagno, R. L. 1998; 18 (3): 168-172

  Abstract

  To evaluate the prevalence of nonprone (supine or side) versus prone sleeping position in healthy preterm infants.A questionnaire on sleeping position was mailed to mothers of 167 preterm infants discharged from the intermediate nursery at Packard Children's Hospital at Stanford. The prevalence of nonprone sleeping at 1 month (term corrected age) and 3 months (2 months corrected age) after nursery discharge was analyzed by an unpaired t test.Nonprone position sleeping occurred in 64% initially and dropped to 35% at 2 months corrected age.Overall, nonprone sleeping was widespread in our healthy preterm infants after hospital discharge but may not persist. A majority of these infants were sleeping prone during a high-risk period for sudden infant death syndrome.

  View details for PubMedID 9659642

• Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia PEDIATRIC INFECTIOUS DISEASE JOURNAL Subramanian, K. N., Weisman, L. E., Rhodes, T., Ariagno, R., Sanchez, P. J., Steichen, J., Givner, L. B., Jennings, T. L., Top, F. H., Carlin, D., Connor, E. 1998; 17 (2): 110-115

  Abstract

  Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants. MEDI-493 (palivizumab) is a humanized monoclonal antibody to the fusion protein of RSV and is active in animal models for prevention of pulmonary RSV replication.To describe the safety, tolerance, immunogenicity and pharmacokinetics of repeat intravenous doses of MEDI-493 in premature infants or infants with bronchopulmonary dysplasia.Phase I/II multicenter, randomized, double blind, placebo-controlled, dose escalation trial.Infants born prematurely (< or = 35 weeks of gestation) who were < or = 6 months of age and infants with bronchopulmonary dysplasia who were < or = 24 months of age were eligible for study participation. STUDY AGENTS: Participants received 3, 10 or 15 mg/kg MEDI-493 or 0.9% saline intravenously every 30 days for up to five doses.MEDI-493 was safe and well-tolerated and did not induce a specific anti-MEDI-493 response. The mean half-life of 20 days was comparable with that of other immunoglobulin G preparations. Mean trough serum concentrations 30 days after Infusion 1 were 6.8, 36.1 and 60.6 microg/ml for the 3-, 10- and 15-mg/kg dose groups, respectively. After Infusion 2 the trough concentrations were 11.9, 45.2 and 70.7 microg/ml. After subsequent doses the mean trough values ranged from 14 to 18 microg/ml in those given 3 mg/kg and were > 40 microg/ml for patients who received 10 or 15 mg/kg MEDI-493 (46 to 72 microg/ml and 88 to 96 microg/ml, respectively).MEDI-493 was safe and well-tolerated in this high risk pediatric population. Mean serum concentrations of MEDI-493 that have been shown to produce a 2-log reduction in pulmonary RSV titer in cotton rats were maintained when 10 or 15 mg/kg MEDI-493 was given every 30 days to pediatric patients at high risk for serious RSV disease. Monthly doses of 15 mg/kg maintained concentrations of > 40 microg/ml for the majority of patients.

  View details for Web of Science ID 000072016900005

  View details for PubMedID 9493805

• Sleeping position in preterm infants does not affect sleep organization. Adams, M. M., Mirmiran, M., Longford, R. V., Kugener, B., Ariagno, R. L. LIPPINCOTT WILLIAMS & WILKINS. 1998: 73A–73A

  View details for Web of Science ID 000071684700385

• Developmental care does not alter sleep and development of premature infants PEDIATRICS Ariagno, R. L., Thoman, E. B., Boeddiker, M. A., Kugener, B., Constantinou, J. C., Mirmiran, M., Baldwin, R. B. 1997; 100 (6)

  Abstract

  The Neonatal Individualized Developmental Care Program (NIDCAP) for very low birth weight (VLBW) preterm infants has been suggested by Als et al to improve several medical outcome variables such as time on ventilator, time to nipple feed, the duration of hospital stay, better behavioral performance on Assessment of Preterm Infants' Behavior (APIB), and improved neurodevelopmental outcomes. We have tested the hypothesis of whether the infants who had received NIDCAP would show advanced sleep-wake pattern, behavioral, and neurodevelopmental outcome.Thirty-five VLBW infants were randomly assigned to receive NIDCAP or routine infant care. The goals for NIDCAP intervention were to enhance comfort and stability and to reduce stress and agitation for the preterm infants by: a) altering the environment by decreasing excess light and noise in the neonatal intensive care unit (NICU) and by using covers over the incubators and cribs; b) use of positioning aids such as boundary supports, nests, and buntings to promote a balance of flexion and extension postures; c) modification of direct hands-on caregiving to maximize preparation of infants for, tolerance of, and facilitation of recovery from interventions; d) promotion of self-regulatory behaviors such as holding on, grasping, and sucking; e) attention to the readiness for and the ability to take oral feedings; and f) involving parents in the care of their infants as much as possible. The infants' sleep was recorded at 36 weeks postconceptional age (PCA) and at 3 months corrected age (CA) using the Motility Monitoring System (MMS), an automated, nonintrusive procedure for determining sleep state from movement and respiration patterns. Behavioral and developmental outcome was assessed by the Neurobehavioral Assessment of the Preterm Infant (NAPI) at 36 weeks PCA, the APIB at 42 weeks PCA, and by the Bayley Scales of Infant Development (BSID) at 4, 12, and 24 months CA.Sleep developmental measures at 3 months CA showed a clear developmental change compared with 36 weeks PCA. These include: increased amount of quiet sleep, reduced active sleep and indeterminate sleep, decreased arousal, and transitions during sleep. Longest sleep period at night showed a clear developmental effect (increased) when comparing nighttime sleep pattern of infants at 3 months with those at 36 weeks of age. Day-night rhythm of sleep-wake increased significantly from 36 weeks PCA to 3 months CA. However, neither of these sleep developmental changes showed any significant effects of NIDCAP intervention. Although all APIB measures showed better organized behavior in NIDCAP patients, neither NAPI nor Bayley showed any developmental advantages for the intervention group. The neurodevelopmental outcome measured by the Bayley at 4, 12, and 24 months CA showed 64% of the NIDCAP intervention group at the lowest possible score compared with 33% of the control group. These findings could not be explained by the occurrence of intraventricular hemorrhage or the socioeconomic status of the parents, which showed no significant group effect.The results of this study, including measures of sleep maturation and neurodevelopmental outcome up to 2 years of age did not demonstrate that the NIDCAP intervention results in increased maturity or development. Buehler et al (Pediatrics. 1995;96:923-932) have reported that premature infants (N = 12; mean gestational age 32 weeks, mean birth weight 1700 g) who received developmental care compared with a similar group of infants who received routine care showed better organized behavioral performance on an APIB assessment at 42 weeks PCA. None of the medical outcome measures were significantly different in this study. Although our APIB results are in agreement, the results of the NAPI, the Bayley and sleep measures do not show an increase in neurodevelopmental maturation. In the earlier report by Als et al (Journal of the American Medical Associatio

  View details for Web of Science ID A1997YJ31400029

  View details for PubMedID 9382910

• Dew-point hygrometry system for measurement of evaporative water loss in infants JOURNAL OF APPLIED PHYSIOLOGY Ariagno, R. L., GLOTZBACH, S. F., Baldwin, R. B., Rector, D. M., Bowley, S. M., Moffat, R. J. 1997; 82 (3): 1008-1017

  Abstract

  Evaporation of water from the skin is an important mechanism in thermal homeostasis. Resistance hygrometry, in which the water vapor pressure gradient above the skin surface is calculated, has been the measurement method of choice in the majority of pediatric investigations. However, resistance hygrometry is influenced by changes in ambient conditions such as relative humidity, surface temperature, and convection currents. We have developed a ventilated capsule method that minimized these potential sources of measurement error and that allowed second-by-second, long-term, continuous measurements of evaporative water loss in sleeping infants. Air with a controlled reference humidity (dew-point temperature = 0 degree C) is delivered to a small, lightweight skin capsule and mixed with the vapor on the surface of the skin. The dew point of the resulting mixture is measured by using a chilled mirror dew-point hygrometer. The system indicates leaks, is mobile, and is accurate within 2%, as determined by gravimetric calibration. Examples from a recording of a 13-wk-old full-term infant obtained by using the system give evaporative water loss rates of approximately 0.02 mgH2O.cm-2.min-1 for normothermic baseline conditions and values up to 0.4 mgH2O.cm-2. min-1 when the subject was being warmed. The system is effective for clinical investigations that require dynamic measurements of water loss.

  View details for Web of Science ID A1997WM77500042

  View details for PubMedID 9074995

• Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis PEDIATRICS Connor, E., TOP, F., Kramer, A., Schneider, M., Love, J., Carlin, D., Siber, G., Leszczynski, J., McIver, J., HEMMING, V., Henson, S., Spruill, S., Colven, C., Wittes, J., Vidyasagar, D., Park, L., Modlin, J. F., Rhodes, T., Pramanik, A. K., Jue, S., Smith, M., Rabalais, G. P., Franco, S., Wilkerson, S., Bibb, K., PICHOFF, B. E., Remich, S., Rettke, M., Weisman, L. E., Mcdonald, M. C., Johnson, K. E., Adams, K., Chartrand, S. A., Wilson, M. C., Redding, G. J., Mayock, D., Hanna, H. J., Stevenson, D. K., Ariagno, R. L., Adams, M. M., Modler, S., Subramanian, S., SMITH, Y. A., Hoy, D. A., Kunos, I., Angelus, P., YOGEV, R., Davis, M., Millard, D. D., Steichen, J. J., GRATTON, T., Bernbaum, J., Banks, B., Zirin, S., Fricko, J., Corcoran, L., Barrett, C. T., Pusser, N. L., Stiehm, R., Cooper, E. R., Fujii, A., Givner, L. B., OSHEA, T. M., Norman, B., Jennings, T. L., Kimura, R. E., Vasan, U., Hennessy, A., Kovacs, A., deLemos, R., Khoury, M., Nachman, S. A., Stobie, P. E., Coggins, J., Perea, K. M., Aronoff, S. C., Lynch, S., Polak, M., BAER, L. S., Hall, C. B., Long, C., Inwood, R., Antonio, E., RAI, B. C., Goyal, M., Solecki, L. E., Lepow, M. L., Horgan, M., Swanson, H., Maynard, R. C., Brasel, D., Werner, K., Oelberg, D. G., Sanchez, P. J., Broyles, S., Zeray, F., Barefield, E. S., Collins, M. V., Desai, S. A., WISWELL, T. E., CULLEN, J. E., Gruber, W. C., Hazinski, T. A., Baker, J., Freeman, S., Settles, O., Gerdes, J. S., Lien, R., CIEPLINSKI, J. A., Hendley, J. O., Boyle, R. J., Robinson, M., PFEFFER, K. D., ROBERTSON, D., Portelli, C., Steinberg, E. A., Fabillar, G., Bloom, D., Zinner, S., Welliver, R. C., Tristram, D. A., Shuff, C., Alessi, K., LEMEN, R., Barton, L., Maleniazi, N., Romano, M. J., Goei, K., Stolz, J. W., Turner, R. B., Wald, E. R., Michaels, M., Green, M., Smail, K., Davey, A. M., Rupar, D. G., Turner, H., Dennehy, P. H., Null, D. M., DUMOIS, J. A., Taaffe, G., Hardy, K., Bushnell, J., Harvey, K., OSULLIVAN, B. P., Spaulding, R., Reuman, P. D., GESSNER, I., Nixon, C., Kumar, M. L., Johnson, C. E., Collin, M., SNIDERMAN, S., Newton, N., Millar, J., Champawat, K., VANDYKE, R. B., Estrada, B., Baley, J. E., Hostoffer, R., Aucott, S. W., Fanaroff, A. A., Eppes, S. C., Childs, J. A., Majure, J. M., Shelton, M. M., Murphey, D. K., Jackson, M. L. 1997; 99 (1): 93-99

  View details for Web of Science ID A1997WB35000017

• Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates JOURNAL OF PEDIATRICS Bernstein, G., Mannino, F. L., Heldt, G. P., Callahan, J. D., BULL, D. H., Sola, A., Ariagno, R. L., HOFFMAN, G. L., Frantz, I. D., TROCHE, B. I., Roberts, J. L., DELACRUZ, T. V., Costa, E. 1996; 128 (4): 453-463

  Abstract

  To compare synchronized intermittent mandatory ventilation (SIMV) and conventional intermittent mandatory ventilation (IMV) in neonates.Prospective, multicenter, randomized clinical trial.Level III neonatal intensive care units at six university or children's hospitals.Three hundred twenty-seven infants receiving conventional IMV for respiratory distress syndrome, pneumonia, or meconium aspiration pneumonitis were randomly assigned a 7.5 +/- 6 hours of age to either continue with IMV or change to SIMV. Infants assigned to each mode of ventilation had similar birth weight (BW), gestational age, and Apgar scores at birth, and similar oxygenation indexes at randomization. They received similar surfactant therapy and had similar incidence of sepsis, seizures, secondary pneumonia, and necrotizing enterocolitis. In the infants with BW less than 1000 gm, more infants receiving IMV had surgical ligation of their patent ductus arteriosus than did those receiving SIMV (27 vs. 7 %; p = 0.02).Data was analyzed overall for all infants and also separately within three BW groups: less than 1000 gm, 1000 to 2000 gm, and more than 2000 gm. The 1000 to 2000 gm BW group was further analyzed in subgroups weighing 1000 to 1499 gm and 1500 to 2000 gm.In all infants, at 1 hour after randomization, the infants receiving SIMV had a lower mean airway pressure than those receiving IMV (8.08 +/- 2.15 vs. 8.63 +/- 2.59; p<0.05), with similar fractions of inspired oxygen and oxygenation indexes. Infants whose BW was 1000 to 2000 gm at 0.5 hour required a lower fraction of inspired oxygen with SIMV than with IMV (0.52 +/- 0.20 vs. 0.62 +/- 0.27; p<0.05) and had better oxygenation at 1 hour, as shown by lower oxygenation indexes with SIMV than with IMV (6.14 +/- 4.17 vs. 9.42 +/- 8.41; p = 0.01). Infants whose BW was 1000 to 2000 gm received a lower number of unit doses of sedative/analgesic drugs per infant during the first 4 days of SIMV than did infants receiving IMV (3.8 +/- 3.4 vs 6.3 +/- 5.5 unit doses; p = 0.02). Infants whose BW was more than 2000 gm had a shorter duration of mechanical ventilation with SIMV than with IMV (median, 72 vs 93 hours; p = 0.02). Three of the forty-six infants receiving IMV but none of the 47 infants receiving SIMV required extracorporeal membrane oxygenation. In the infants with BW less than 1000 gm, fewer infants treated with SIMV required supplemental oxygen at 36 weeks of postconceptional age than did those treated with IMV (47 vs 72%; p<0.05). In 83 infants whose lungs were mechanically ventilated for 14 days or longer, all with BW less than 2000 gm, those treated with SIMV regained their BW earlier than those treated with IMV (median, 21.5 vs 29 days; p<0.01). There were no differences in the rates of death, intraventricular hemorrhage (grades III and IV), air leak, need for pharmacologic paralysis, or need for supplemental oxygen at 28 days.We found that SIMV was at least as efficacious as conventional IMV, and may have improved certain outcomes in BW-specific groups.

  View details for Web of Science ID A1996UF24400002

  View details for PubMedID 8618177

• Effects of sleeping position on clinical variables in healthy preterm infants. Adams, M. M., Kugener, B., Ariagno, R. L. NATURE PUBLISHING GROUP. 1996: 1124–24

  View details for Web of Science ID A1996UD23801124

• Effect of sleeping position on clinical variables in healthy preterm infants Adams, M. M., Kugener, B., Ariagno, R. L. LIPPINCOTT WILLIAMS & WILKINS. 1996: A162–A162

  View details for Web of Science ID A1996TP69000863

• A SURVEY OF SLEEPING POSITION PRACTICES IN PRETERM INFANTS Adams, M. M., Kugener, B., Ariagno, R. L. NATURE PUBLISHING GROUP. 1995: A192–A192

  View details for Web of Science ID A1995QP08201134

• BIOLOGICAL RHYTHMICITY IN PRETERM INFANTS PRIOR TO DISCHARGE FROM NEONATAL INTENSIVE-CARE PEDIATRICS GLOTZBACH, S. F., Edgar, D. M., Ariagno, R. L. 1995; 95 (2): 231-237

  Abstract

  The study of biological rhythms and the influence of environmental factors in the timing and synchronization of different rhythmic events have important implications for neonatal health. Preterm infants in the neonatal intensive care unit (NICU) are deprived of the patterned influences of maternal sleep, temperature, heart rate, and hormonal cycles. The impact of the NICU and nursing interventions on the development of the circadian system was studied in 17 stable preterm infants in the Intermediate Intensive Care Nursery at Stanford University for three consecutive days at about 35 weeks postconceptional age.Rectal temperature, abdominal skin temperature, heart rate, and activity were simultaneously recorded at 2-minute intervals during each 3-day study by a small microcomputer (Vitalog).Very low amplitude circadian rhythms were found for rectal and skin temperatures (maximum range 36.8 to 37.0 degrees C); population mean values for heart rate (158 bpm) and activity (3.5 counts per 2-min bin) did not differ significantly as a function of time of day. Rectal temperature, averaged in 6-hour bins over the 24-hour day as a function of both postconceptional age and postnatal age, was significantly higher during the first part of the circadian cycle. In all infants, rhythmicity in each variable was dominated by ultradian periodicities that were coincident with feedings and related interventions; moreover, several physiological variables charted during feeding differed significantly from values obtained during periods in which caregiving interventions did not occur.Quantitative data on the preterm infant circadian system may facilitate evaluation of factors that improve therapeutic responses, recovery, and outcome of neonatal intensive care patients.

  View details for Web of Science ID A1995QE31300014

  View details for PubMedID 7838641

• BIOLOGICAL RHYTHMICITY IN NORMAL INFANTS DURING THE FIRST 3 MONTHS OF LIFE PEDIATRICS GLOTZBACH, S. F., Edgar, D. M., Boeddiker, M., Ariagno, R. L. 1994; 94 (4): 482-488

  Abstract

  The mammalian "biological clock," which resides in the hypothalamic suprachiasmatic nucleus, has an important role in both the timing and organization of sleep and in the coordination of sleep with other physiological rhythms such as temperature regulation and respiratory control. We wished to describe the development of the circadian system in normal infants during the first 3 months of life.Ten healthy full term infants were studied in the infant's home for three consecutive days at 1 month and 3 months postnatal age. Rectal temperature, abdominal skin temperature, heart rate, and activity were recorded at 2-minute intervals during each study using a small microcomputer.Circadian periodicity for most variables was seen at 1 month of age and significantly increased at 3 months. Differences in the pattern of rhythmicity during these two developmental periods were highlighted by an increase in activity during the subjective day and a decrease in Trec during the subjective night at 3 months compared to 1 month. Correlational analysis revealed that all pairs of variables, exclusive of Tsk, showed a significantly higher association at 3 months relative to 1 month. The lengthening of the interfeeding interval at 3 months of age corresponded with an increased consolidation of sleep during the night and a relatively lower nocturnal body temperature minima compared to 1 month of age.The results of this study underscore the subtle changes in the nature and interaction of several infant variables during this critical developmental period, which may reflect maturation of the circadian system and its coupling with homeostatic effector systems that are developing in parallel.

  View details for Web of Science ID A1994PK84000013

  View details for PubMedID 7936856

• LIGHT VARIABILITY IN THE MODERN NEONATAL NURSERY - CHRONOBIOLOGIC ISSUES MEDICAL HYPOTHESES GLOTZBACH, S. F., ROWLETT, E. A., Edgar, D. M., Moffat, R. J., Ariagno, R. L. 1993; 41 (3): 217-224

  Abstract

  The role that nursery light variability may play in modulating infant biological rhythms is being studied in Stanford Medical Center's Neonatal Intensive Care (NICU) and Intermediate Care (IN) Nurseries. In this investigation, spatial and temporal variability in illuminance was determined at 20 sites within each nursery over a 5-day period. The analysis of 240 measurements at 30 min intervals from each site revealed marked variability in illumination with respect to both time and position in the nursery. These aperiodic lighting patterns differed greatly from the published characterization of NICUs as having 'constant' illumination. Light pulses of variable frequency, intensity, and duration were common at each of the 40 bedsites studied. Given the powerful impact of light on circadian rhythmicity and sleep in adults, the results from this study suggest that modern NICU lighting, while implemented to facilitate intensive care, may have adverse effects on infant development. Future studies on the influence of light on biological rhythmicity and sleep are essential to provide a framework for clinical and environmental interventions, which may play a significant role in improving developmental outcome in hospitalized preterm or term infants.

  View details for Web of Science ID A1993LX72000006

  View details for PubMedID 8259078

• DELAYED COMPLIANCE INCREASE IN INFANTS WITH RESPIRATORY-DISTRESS SYNDROME FOLLOWING SYNTHETIC SURFACTANT PEDIATRIC PULMONOLOGY ARMSBY, D. H., Bellon, G., Carlisle, K., Rector, D., Baldwin, R., Long, W., Stevenson, D. K., Ariagno, R. L. 1992; 14 (4): 206-213

  Abstract

  Recent research has demonstrated that Exosurf (EXSF), a newly synthesized artificial surfactant, increases survival when administered endotracheally to premature infants with RDS. This study examines the effects of EXSF on static respiratory system compliance (Crs). Thirty-four patients received two doses of EXSF in this rescue protocol. Crs (mL/cmH2O/kg) did not significantly change within the first 4 hours after either dose. However, Crs values did increase significantly (paired Student's t-test, P = 0.005) when data collected after the second dose (0.36 +/- 0.13 mL/cmH2O/kg) were compared to first week follow-up data (0.51 +/- 0.21 mL/cmH2O/kg). Crs data collected between 2 and 4 weeks after treatments were again not significantly different from non-concurrent control data collected at 3-4 weeks of life. The measurement of Crs in infants receiving EXSF may have been affected by an increase in lung inflation, which could mask an increase in Crs. We speculate that improved lung inflation may occur with less barotrauma in the first week of life due to surfactant replacement treatment and may in part explain the improved Crs seen at 1 week of age. Many investigators using different surfactants, dosing schedules, and pulmonary function methodologies to evaluate lung mechanics have reported that the improvement in compliance after surfactant treatment usually follows the clinical improvement in gas exchange. Additional studies are needed to explain the mechanism of early improvement following surfactant replacement in infants with RDS.

  View details for Web of Science ID A1992KD24300002

  View details for PubMedID 1484754

• NONINVASIVE METHODS FOR ESTIMATING INVIVO OXYGENATION CLINICAL PEDIATRICS Benaron, D. A., Benitz, W. E., Ariagno, R. L., Stevenson, D. K. 1992; 31 (5): 258-273

  Abstract

  Clinical signs of hypoxia and hyperoxia are nonspecific and unreliable, yet both are potentially injurious. Noninvasive methods of oxygen assessment fill the gap between clinical observation and invasive tests, helping physicians deliver sufficient oxygen with minimum toxicity. Potential sites for oxygen measurement vary between the blood and the mitochondria; each method measures at a different site and detects different types of hypoxia and hyperoxia. Thus, values obtained by two different methods are not equivalent, giving each method unique strengths and weaknesses. We review two clinical methods (pulse oximetry and transcutaneous oximetry), as well as four experimental methods (near-infrared spectrophotometry, magnetic resonance spectroscopy, magnetic resonance saturation imaging, and time-of-flight absorbance spectrophotometry). The principles of each method and the clinical situations in which each succeeds or fails are discussed. A fundamental understanding of each method can help in deciding which methods, if any, are appropriate for a given patient and how best to correct observed oxygenation problems once they are discovered.

  View details for Web of Science ID A1992HU95600001

  View details for PubMedID 1582091

• PLASMA DOPAMINE, NOREPINEPHRINE, EPINEPHRINE AND DOPAC LEVELS IN PRETERM INFANTS PRIOR TO AND IMMEDIATELY AFTER A SLEEP VENTILATION HYPERCARBIA TEST ACTA PAEDIATRICA SCANDINAVICA Dalmaz, Y., Ariagno, R. L., Bellon, G., Challamel, M. J., Peyrin, L. 1991; 80 (11): 1008-1013

  Abstract

  The postnatal maturation and the adaptational ability of the sympathoadrenal system has been investigated in preterm neonates (n = 8), and in sick preterm neonates with respiratory disorders (n = 10). Plasma levels of dopamine (DA), norepinephrine (NE), epinephrine (E) and 3-4 dihydroxyphenylacetic acid (DOPAC) were evaluated at rest during the first month of life, and following an inhalation of a 5% carbon dioxide-21% oxygen mixture for 10 min. During the first month of life the sick preterm neonates exhibited similar NE, E, and DOPAC plasma levels but higher DA amounts than healthy infants. Plasma DA levels were inversely correlated with the transcutaneous oxygen tension (r = -0.636) indicating that hypoxemia was able to enhance the release of DA. Immediately following the hypercarbia test, there were no significant changes of plasma catecholamine levels in the sick preterms, but there was a significant increase of E plasma levels (+140%, p less than 0.05) and a moderate elevation of NE and DA amounts in the healthy preterms. It is concluded that preterm neonates who have had respiratory disorders did not exhibit an immaturity of the sympathoadrenal system at rest, but had a defect in the release of E following hypercarbia exposure, which may be secondary to an alteration in chemoreceptor function and/or reduced catecholamine stores.

  View details for Web of Science ID A1991GP01700003

  View details for PubMedID 1750332

• A CONTROLLED TRIAL OF AEROSOLIZED RIBAVIRIN IN INFANTS RECEIVING MECHANICAL VENTILATION FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS-INFECTION NEW ENGLAND JOURNAL OF MEDICINE Smith, D. W., Frankel, L. R., Mathers, L. H., TANG, A. T., Ariagno, R. L., Prober, C. G. 1991; 325 (1): 24-29

  Abstract

  Although the antiviral agent ribavirin improves the course of lower respiratory tract disease in spontaneously breathing infants with respiratory syncytial virus infection, it is not known whether ribavirin can benefit infants with severe respiratory syncytial virus disease who require mechanical ventilation.We conducted a randomized, double-blind, placebo-controlled evaluation of ribavirin (20 mg per milliliter) administered continuously in aerosolized form to infants receiving mechanical ventilation for respiratory failure that was caused by documented respiratory syncytial virus infection.Of the 28 infants (mean [+/- SD] age, 1.4 +/- 1.7 months) enrolled, 7 had underlying diseases predisposing them to severe infection (mean age, 3.0 +/- 2.6 months), and 21 were previously normal (mean age, 0.8 +/- 0.9 month). Among the 14 infants who received ribavirin, the mean duration of mechanical ventilation was 4.9 days (as compared with 9.9 days among the 14 who received placebo; P = 0.01), and the mean length of supplemental oxygen use was 8.7 days (as compared with 13.5 days; P = 0.01). The mean length of the hospital stay was 13.3 days after treatment with ribavirin and 15.0 with placebo (P = 0.04). When only the 21 previously normal infants were considered, the mean length of the hospital stay was 9.0 days for the ribavirin recipients and 15.3 days for those who received placebo (P = 0.005).In infants who require mechanical ventilation because of severe respiratory syncytial virus infection, treatment with aerosolized ribavirin decreases the duration of mechanical ventilation, oxygen treatment, and the hospital stay.

  View details for Web of Science ID A1991FU34200005

  View details for PubMedID 1904551

• AEROSOLIZED RIBAVIRIN IN INFANTS REQUIRING MECHANICAL VENTILATION FOR SEVERE LOWER RESPIRATORY-TRACT INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS Smith, D. W., Frankel, L. R., Mathers, L. H., TANG, A. T., Ariagno, R. L., Prober, C. G. SLACK INC. 1991: A59–A59

  View details for Web of Science ID A1991ET78600326

• PULMONARY-FUNCTION TESTING IN INFANTS WITH RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS REQUIRING MECHANICAL VENTILATION PEDIATRIC INFECTIOUS DISEASE JOURNAL Smith, D. W., Rector, D. M., Derish, M. T., Frankel, L. R., Ariagno, R. L. 1990; 9 (9): S108-S111

  View details for Web of Science ID A1990DY65700016

  View details for PubMedID 2235204

• Neonatal tuberous sclerosis: magnetic resonance appearance of subependymal tubers. Australasian radiology Dawson, K. L., Moore, S. G., Ariagno, R. L. 1990; 34 (3): 247-248

  Abstract

  A case of tuberous sclerosis in a neonate, with cerebral and cardiac hamartomas evaluated by MR imaging, is presented. Intracranial subependymal tubers in this neonate exhibit increased signal intensity on short TR images. This differs from the signal characteristics of subependymal tubers in older patients.

  View details for PubMedID 2275684

• Fatal postoperative Legionella pneumonia in a newborn. Journal of perinatology Greene, K. A., Rhine, W. D., Starnes, V. A., Ariagno, R. L. 1990; 10 (2): 183-184

  Abstract

  This is a case of postoperative Legionella pneumonia in a full-term infant with hypoplastic left heart syndrome. The infant had an uncomplicated prenatal history, normal vaginal delivery, Apgars of 8 at 1 and 5 minutes, but was cyanotic at birth. At 3 days of age she had a stage 1 Norwood surgical procedure to palliate her congenital heart disease. A synthetic patch was placed over the thoracic midline because of difficulty in reapposing the sternum. Peritoneal dialysis was used to manage renal failure. At 20 days of age she had disseminated intravascular coagulopathy and pneumonia associated with sepsis. Four days later she died. Legionella pneumophila serogroup 1 was isolated from a lung culture taken at autopsy.

  View details for PubMedID 2358903

• PERIODIC BREATHING IN PRETERM INFANTS - INCIDENCE AND CHARACTERISTICS PEDIATRICS GLOTZBACH, S. F., Baldwin, R. B., LEDERER, N. E., Tansey, P. A., Ariagno, R. L. 1989; 84 (5): 785-792

  Abstract

  The prevalence and characteristics of periodic breathing in preterm infants were measured by 24-hour impedance pneumograms in 66 preterm infants before discharge from the nursery. Four periodic breathing parameters (percentage of periodic breathing per quiet time, number of episodes of periodic breathing per 100 minutes of quiet time, mean duration of periodic breathing, and longest episode of periodic breathing) were compared to data available from healthy term infants and from term infants who subsequently died of sudden infant death syndrome (SIDS). Periodic breathing was found in all preterm infants studied and mean periodic breathing parameter values (12.0%, 8.6 episodes, 1.2 minutes, and 7.3 minutes, respectively) in our preterm population were substantially higher than values from healthy term infants and SIDS victims. Most periodic breathing parameters decreased significantly in infants studied at 39 to 41 weeks' postconceptional age compared with earlier postconceptional age groups. No relationship was found between central apneas of greater than or equal to 15 seconds' duration and postconceptional age or any periodic breathing parameter. Periodic breathing is a common respiratory pattern in preterm infants that is usually not of pathologic significance. Associations between elevated levels of periodic breathing and respiratory dysfunction or SIDS should be made with caution.

  View details for Web of Science ID A1989AX61000008

  View details for PubMedID 2797974

• THE EFFECT OF DEXAMETHASONE ON CHRONIC PULMONARY OXYGEN-TOXICITY IN INFANT MICE PEDIATRIC RESEARCH Ohtsu, N., Ariagno, R. L., Sweeney, T. E., Davis, L., Moses, L., PETRICEKS, R., DAEHNE, I., Bensch, K., Northway, W. H. 1989; 25 (4): 353-359

  Abstract

  The effect of dexamethasone (0.1, 1, and 5 mg/kg/d given subcutaneously from d 14-18) was tested in infant mice continuously exposed from birth to either humidified air or 80% oxygen. Dexamethasone significantly decreased lung wet wt (p less than 0.01), lung water (p less than 0.021), lung dry wt, protein, and DNA (p less than 0.001) in both air- and oxygen-exposed animals. Dexamethasone, however, had no effect on lung compliance measured after animals were killed on d 18. It also had no effect on the increase in the blood-air barrier thickness or decrease in the blood-air exchange surface area seen in the 80% oxygen-exposed mice. Dexamethasone decreased thymus gland wt (p less than 0.001), body wt gain (p less than 0.001), brain wt (p less than 0.001), and lung lymphocytes (p less than 0.05) in both air- and oxygen-exposed animals. The effect of 1 mg/kg and 5 mg/kg of the drug could not be differentiated. During the 4 d of drug administration, one air- and one oxygen-exposed animal died; both received 5 mg/kg/d of dexamethasone; microscopic and culture evidence of infection was not found. If dexamethasone causes similar effects in human infants with bronchopulmonary dysplasia, it should be used with great caution even for short-term clinical management.

  View details for Web of Science ID A1989T947000008

  View details for PubMedID 2726308

• PERIODIC BREATHING CYCLE DURATION IN PRETERM INFANTS PEDIATRIC RESEARCH GLOTZBACH, S. F., Tansey, P. A., Baldwin, R. B., Ariagno, R. L. 1989; 25 (3): 258-261

  Abstract

  Periodic breathing cycle duration (PCD), the time interval from the beginning of one respiratory pause to the beginning of the next pause within an episode of periodic breathing (PB), was measured by examination of 24-h impedance pneumograms in 51 preterm infants. Calculations of the SD of PCD within a given PB episode (approximately 3 s) and comparison of PCD values between two PB episodes in each infant (r = 0.68) revealed considerable variability in PCD. This variability was not related to the number of cycles in the PB episode or to the amount of PB in the recording. Contrary to the decrease in PCD from 15.0 s at 1 wk to 12.4 s at 12 wk in term infants reported previously, PCD did not vary as a function of postconceptional, gestational, or postnatal age in our preterm population. PCD has limited value as an indicator of chemoreceptor maturation in the preterm infant, and most likely reflects transient adjustments in respiratory system control.

  View details for Web of Science ID A1989T593200007

  View details for PubMedID 2704592

• A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF EFFECTS OF DEXAMETHASONE ON HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN PRETERM INFANTS JOURNAL OF PEDIATRICS Wilson, D. M., Baldwin, R. B., Ariagno, R. L. 1988; 113 (4): 764-768

  Abstract

  As part of a blinded, randomized, placebo-controlled study of dexamethasone therapy in 27 preterm infants with bronchopulmonary dysplasia, we investigated the effect of 7 days of high-dose glucocorticoid therapy on the hypothalamic-pituitary-adrenal axis. Before therapy the median basal cortisol concentration in all infants was 8.2 micrograms/dl (226 nmol/L). After stimulation with 1-24 ACTH, the serum cortisol concentration rose in all infants to a median concentration of 23.5 micrograms/dl (649 nmol/L), resulting in a median rise of 13.4 micrograms/dl (37 nmol/L). Immediately after 7 days of glucocorticoid therapy basal and peak cortisol concentrations were significantly decreased in the dexamethasone group. The rise in serum cortisol following 1-24 ACTH, however, remained equivalent in both groups. Ten days after the end of therapy basal and peak cortisol concentrations in the dexamethasone group had returned to levels equivalent to those seen in the placebo group. Weight gain was markedly diminished while the infants were receiving dexamethasone. Weight gains were, however, equivalent 10 days after the end of treatment. These data indicate that 7 days of dexamethasone therapy has significant but short-term effects on cortisol secretion and possibly on weight gain.

  View details for PubMedID 3050006

• INTERFERENCE OF FETAL HEMOGLOBIN WITH THE SPECTROPHOTOMETRIC MEASUREMENT OF CARBOXYHEMOGLOBIN CLINICAL CHEMISTRY Vreman, H. J., RONQUILLO, R. B., Ariagno, R. L., Schwartz, H. C., Stevenson, D. K. 1988; 34 (5): 975-977

  Abstract

  We measured the concentration of carboxyhemoglobin (HbCO) in blood samples from 32 neonates by spectrophotometry (IL282 CO-Oximeter) and gas chromatography, finding a strong positive correlation (r = 0.89) between the concentration of fetal hemoglobin (Hb F) and HbCO as measured by spectrophotometry, but not by gas chromatography. Thus, Hb F interferes with the determination of HbCO by spectrophotometric techniques by falsely increasing apparent HbCO in direct proportion to Hb F. We conclude that, when Hb F is known or suspected to be present, blood HbCO cannot be reliably determined by methods based on spectrophotometry.

  View details for Web of Science ID A1988N563700035

  View details for PubMedID 2453310

• DISSOCIATION OF MEAN AIRWAY PRESSURE AND LUNG-VOLUME DURING HIGH-FREQUENCY OSCILLATORY VENTILATION CRITICAL CARE MEDICINE Smith, D. W., Frankel, L. R., Ariagno, R. L. 1988; 16 (5): 531-535

  Abstract

  Eight kittens were studied during high-frequency oscillatory ventilation (HFOV) using an airway vibrator. HFOV was performed at 1000 and 1800 cycle/min at three present oscillatory amplitude settings and with lungs normal and injured by saline lavage. Change in lung volume (LV) during HFOV was compared to change in LV obtained during static inflation at matched mean airway pressure (Paw) of 5, 10, 15 and 20 cm H2O. LV during HFOV was significantly higher than during static inflation, and increased as oscillatory amplitude increased. LV was significantly lower after lung injury for matched HFOV settings, and was not affected by rate. Dissociation of Paw and LV during HFOV is observed implying that mean alveolar pressure (Palv) exceeds Paw during HFOV in this experimental model. The safe clinical application of HFOV may involve measurement of Palv or LV.

  View details for Web of Science ID A1988N250700012

  View details for PubMedID 3359791

• RAPID ASSESSMENT OF VENTILATION BY MEASUREMENT OF CARBON-DIOXIDE ELIMINATION DURING HIGH-FREQUENCY VENTILATION OF KITTENS PEDIATRIC PULMONOLOGY Smith, D. W., Frankel, L. R., Walker, J. G., Cheng, E. Y., MEREDITH, K. S., Mihm, F. G., Ariagno, R. L. 1987; 3 (6): 406-412

  Abstract

  Monitoring of the effectiveness of ventilation is a significant problem during high-frequency ventilation (HFV). The time necessary to achieve equilibrium of the arterial tension of carbon dioxide (Paco2) following step changes in ventilation is appreciable, because of large body stores of CO2. Waiting for Paco2 to reach equilibrium is not only time-consuming but a potentially dangerous means of monitoring ventilator adjustments during HFV. Five kittens of mean +/- SD 1,082 +/- 383 gm weight were studied during HFV, both with normal lungs and lungs injured by saline lavage-induced surfactant depletion. The transcutaneous tension of carbon dioxide (Ptcco2) was monitored continuously to determine the time required to achieve equilibrium of Paco2 following a step change in ventilation. The rate of pulmonary CO2 elimination (VECO2) was measured immediately before and immediately after (less than 12 sec) step changes in ventilation and was used to predict the change in Paco2 achieved once equilibrium was reestablished. With normal lungs, equilibration time following step changes in ventilation was found to be approximately 20 minutes. After step decreases in ventilation of the injured lung, achieving equilibrium state took significantly longer, approximately 30 minutes. The Paco2 predicted was significantly related to the change in Paco2 achieved at equilibrium for both normal and injured lung studies. We concluded that direct monitoring of VECO2 during HFV may be a useful clinical monitoring technique, allowing rapid and accurate assessment of the efficiency of ventilation following step changes in ventilation and potentially assisting in optimizing ventilator settings.

  View details for Web of Science ID A1987L110400004

  View details for PubMedID 3122154

• HOME MONITORING OF HIGH-RISK INFANTS CHEST Ariagno, R. L., GLOTZBACH, S. F. 1987; 91 (6): 898-900

  View details for Web of Science ID A1987H591600024

  View details for PubMedID 3581938

• THE BABY-DOE RULE JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Stevenson, D. K., Ariagno, R. L., Kutner, J. S., Raffin, T. A., Young, E. W. 1986; 255 (14): 1909-1912

  View details for Web of Science ID A1986A718900029

  View details for PubMedID 3951118

• DEXAMETHASONE DECREASES LUNG WATER WITHOUT AFFECTING LUNG COMPLIANCE IN NEWBORN MICE RAISED IN 80-PERCENT OXYGEN ENVIRONMENT Ariagno, R. L., Sweeney, T. E., Northway, W. H., Ohtsu, N., Bensch, K. AMER THORACIC SOC. 1986: A108–A108

  View details for Web of Science ID A1986A740800391

• USE OF SODIUM-NITROPRUSSIDE IN NEONATES - EFFICACY AND SAFETY JOURNAL OF PEDIATRICS Benitz, W. E., MALACHOWSKI, N., Cohen, R. S., Stevenson, D. K., Ariagno, R. L., Sunshine, P. 1985; 106 (1): 102-110

  Abstract

  Sodium nitroprusside was administered to 58 neonates, including 11 with severe respiratory distress syndrome, 15 with persistent pulmonary hypertension of the newborn, 28 with clinical shock, three with systemic hypertension, and two with pulmonary hypoplasia, all refractory to conventional intensive therapy. Nitroprusside was infused at 0.2 to 6.0 micrograms/kg/min for periods of 10 minutes to 126 hours. Infants with severe respiratory distress syndrome had increased PaO2 and decreased PaCO2 or peak inspiratory pressure, and nearly all (82%) survived. Infants with persistent pulmonary hypertension of the newborn had variable responses; improvement did not correlate with survival, but survival (47%) was identical to that in an earlier series of infants given tolazoline. Infants in shock had improved perfusion, urine output, and serum bicarbonate levels, and these responses were significantly related to survival. Hypertension was controlled in all three hypertensive infants. Adverse effects were very uncommon. Toxic effects were not observed. Sodium nitroprusside is effective and can be used safely in circulatory disorders in the neonate.

  View details for Web of Science ID A1985AAH1500023

  View details for PubMedID 3917495

• GROWTH FAILURE SECONDARY TO DEXAMETHASONE IN PRETERM NEONATES Sweeney, T., Benitz, W. E., Baldwin, R. E., Ariagno, R. L. SLACK INC. 1985: A149–A149

  View details for Web of Science ID A1985TY84700878

• GROWTH FAILURE DURING DEXAMETHASONE THERAPY IN PRETERM NEONATES Sweeney, T., Benitz, W., Baldwin, R., Ariagno, R. L. INT PEDIATRIC RESEARCH FOUNDATION, INC. 1985: A367–A367

  View details for Web of Science ID A1985AEU1801537

• SEQUELAE OF ACQUIRED CYTOMEGALO-VIRUS INFECTION IN PREMATURE AND SICK TERM INFANTS JOURNAL OF PEDIATRICS PARYANI, S. G., YEAGER, A. S., HOSFORDDUNN, H., Johnson, S. J., MALACHOWSKI, N., Ariagno, R. L., Stevenson, D. K. 1985; 107 (3): 451-456

  Abstract

  To assess the risk of long-term sequelae after acquired cytomegalovirus (CMV) infection in premature and sick term infants, 55 CMV infected patients were matched prospectively with 55 control patients and these matched pairs were evaluated at 3 years of age. Sensorineural hearing losses were present in four of 43 CMV infected patients (all mild-moderate) and in two of 43 controls (one severe). The incidence of neurologic sequelae was not increased in CMV infected patients with birth weight greater than 2000 gm. Among patients with birth weight less than 2001 gm, moderately abnormal EEGs were found in four (17%) of 23 CMV infected patients and in one (4%) of 23 controls, and severe handicaps occurred in four (14%) of 29 CMV infected patients and in two (7%) of 29 controls. Severe handicaps in premature infants were significantly (P less than 0.05) associated with early onset of CMV excretion (less than 8 weeks of age) and severe cardiopulmonary disease. Among the premature infants who were documented early excretors, three of 13 had severe neuromuscular impairment, four of 13 had severe handicaps (DQ less than 70, severe neuromuscular impairment, or profound loss of vision or hearing), and an additional four had DQs of 70 to 79. Among their matched control subjects, none of 13 had severe neuromuscular impairment, two of 13 had severe handicaps, and an additional two had DQs between 70 and 79. None of the premature infants who were documented late excretors (greater than or equal to 8 weeks of age) had any neurologic sequelae. The risk of neurologic sequelae and handicap may be increased in premature infants with onset of CMV excretion in the first 2 months of life.

  View details for Web of Science ID A1985AQU3800028

  View details for PubMedID 2993576

• NEAR-MISS SUDDEN INFANT DEATH SYNDROME IN 8 INFANTS WITH SLEEP APNEA-RELATED CARDIAC-ARRHYTHMIAS PEDIATRICS Guilleminault, C., Ariagno, R., Coons, S., WINKLE, R., KOROBKIN, R., Baldwin, R., Souquet, M. 1985; 76 (2): 236-242

  Abstract

  Eight full-term infants between 3 and 8 weeks of age, who had had 24 to 48 hours of vague problems involving a congested upper airway and/or irritability, had a life-threatening respiratory episode at home, called a near-miss for sudden infant death syndrome event. Polygraphically monitored mixed apneas occurred in clusters during non-rapid eye movement (NREM) sleep with significant cardiac arrhythmias, predominantly sinus arrest. The cardiorespiratory problems continued during sleep in the following 8 to 12 weeks but did not recur after that time, and there were no long-term sequelae when the children were studied again 4 to 7 years later.

  View details for Web of Science ID A1985ANM9200015

  View details for PubMedID 4022698

• APNEA DURING SLEEP IN THE PEDIATRIC-PATIENT CLINICS IN CHEST MEDICINE Ariagno, R. L., Guilleminault, C. 1985; 6 (4): 679-690

  Abstract

  Pediatric respiratory disorders during sleep are primarily apneic problems that can be associated with a number of abnormalities. When apnea is secondary to a disease process, the main focus should be on the identification of that disease process and on the institution of appropriate therapy. When the apnea persists or when it is idiopathic, additional evaluation may be required to identify an appropriate course of management.

  View details for Web of Science ID A1985AWN0400013

  View details for PubMedID 3936666

• 5 CASES OF NEAR-MISS SUDDEN INFANT DEATH SYNDROME AND DEVELOPMENT OF OBSTRUCTIVE SLEEP-APNEA SYNDROME PEDIATRICS Guilleminault, C., Souquet, M., Ariagno, R. L., KOROBKIN, R., SIMMONS, F. B. 1984; 73 (1): 71-78

  Abstract

  Five full-term infants were referred for "near miss" sudden infant death syndrome events, which occurred between 3 and 12 weeks of age. After a complete pediatric evaluation and 24-hour polygraphic monitoring, each infant was monitored at home with a cardiorespiratory monitor. Each was followed regularly (with repeat polygraphic recordings) up to 4 years of age. All five infants developed heavy snoring at night and symptoms of obstructive sleep apnea syndrome. The diagnosis of obstructive sleep apnea syndrome was confirmed by polygraphic recordings; surgery was recommended. Four of the five children underwent adenoidectomies between 3 and 4 years of age, and this significantly improved their condition. These five cases are the first polygraphically documented histories of the development of obstructive sleep apnea syndrome.

  View details for Web of Science ID A1984RX66800016

  View details for PubMedID 6691044

• SURVIVAL AND MORBIDITY OF OUR SMALLEST BABIES - IS THERE A LIMIT TO NEONATAL CARE PEDIATRICS Cohen, R. S., Stevenson, D. K., Ariagno, R. L., Sunshine, P. 1984; 73 (3): 415-416

  View details for Web of Science ID A1984SG26800040

  View details for PubMedID 6701075

• EVALUATION AND MANAGEMENT OF INFANTILE APNEA PEDIATRIC ANNALS Ariagno, R. L. 1984; 13 (3): 210-?

  Abstract

  Knowledge regarding the etiology and optimal management of prolonged apnea and its relationship to SIDS is still limited. The majority of infants with prolonged apnea do not die of SIDS, although the risk of SIDS in this group is greater than in the general population. Many infants with prolonged apnea who are perceived by parents and physicians as having had a "life-threatening" event may be at risk for another. Appropriate assessment following this event includes a careful history and physical examination to determine cause and severity. Etiologies to be considered include infections, metabolic aberrations, seizure problems, cardiac arrhythmias or congenital heart disease, anatomic airway abnormalities, gastroesophageal reflux and impaired regulation of breathing. If a specific cause has been identified for the infant's apnea, appropriate treatment often will lead to resolution of the apnea problem. If a specific etiology has not been identified or if the risk of "life-threatening" prolonged apnea seems to persist, electronic cardiorespiratory monitoring may be considered. Appropriate treatment for asymptomatic infants who are at increased statistical risk of SIDS is controversial. Asymptomatic infants may be candidates for home monitoring, but as yet, there are no reliable tests to predict which infants are at risk for prolonged apnea. Monitoring at home must be prescribed by the physician and should be continued until judged no longer appropriate by the attending physician. Skilled caregivers are crucial to the continuous observation and management of these patients in the hospital and at home. Therefore parents should be taught monitor use and also CPR.(ABSTRACT TRUNCATED AT 250 WORDS)

  View details for Web of Science ID A1984SG98100003

  View details for PubMedID 6709408

• NEONATAL BILIRUBIN PRODUCTION ESTIMATED FROM END-TIDAL CARBON-MONOXIDE CONCENTRATION JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION Smith, D. W., Hopper, A. O., SHAHIN, S. M., Cohen, R. S., OSTRANDER, C. R., Ariagno, R. L., Stevenson, D. K. 1984; 3 (1): 77-80

  Abstract

  The relationship between the pulmonary excretion rate of carbon monoxide (VECO) and the concentration of CO, in a sample of breath, drawn through a nasopharyngeal catheter at end-expiration, was assessed in 25 studies of nine preterm and 14 term infants. The VECO and this approximate end-tidal sample of CO (ETCO) correlated significantly over a wide range of CO elimination rates: VECO = 10.45 ETCO + 2.25 (n = 25, r = 0.95). The ETCO correctly predicted elevations in VECO greater than 2 SD of the mean VECO for normal infants (13.9 +/- 3.5 microliter/kg/h), with 90% sensitivity and 73% specificity (p less than 0.01). Three subjects with Rh isoimmune hemolytic disease were easily identified by the ETCO as well as the VECO. The ETCO is a simple, noninvasive measurement for rapidly identifying infants with significant hemolytic disease.

  View details for Web of Science ID A1984RW76000017

  View details for PubMedID 6537974

• PREDICTING SURVIVAL AMONG VENTILATOR-DEPENDENT VERY LOW-BIRTH-WEIGHT INFANTS CRITICAL CARE MEDICINE KIMBLE, K. J., Ariagno, R. L., Stevenson, D. K., Sunshine, P. 1983; 11 (3): 182-185

  Abstract

  Ventilator-bound very low birth weight (VLBW) infants represent an increasing proportion of our nursery population. We reviewed the hospital course of 38 VLBW infants who required more than 1 month of intermittent mandatory ventilation (IMV) between 1976 and 1978. Twenty-eight infants survived; 10 died. There were no significant differences between survivors and nonsurvivors in estimated gestational age (EGA), Apgar scores, first pH, first mean arterial pressure (MAP), h of IMV required, or birth weight; nor did the incidence of patent ductus arteriosus (PDA), respiratory distress syndrome (RDS), or transport differ. Pneumothorax was significantly more common among those infants who died. When ventilator settings were reviewed, significant differences were found consistently between the 2 groups of 3, 5, and 7 days of age, but not at 1, 14, 21, or 28 days of age. A predictive model for estimating the probability of survival of such infants was developed based upon these data, employing birth weight, mean airway pressure (MAWP) at 7 days of age, and occurrence of pneumothorax, and was applied prospectively to a group of 29 such infants born in 1979 and 1980. Prediction of outcome was significantly more accurate than chance alone. We conclude that prolonged ventilator dependence is largely confined to VLBW infants; that it is the rule among infants less than 750 g; and that accurate, objective assessment of an individual infant's prognosis may lead to improved care.

  View details for Web of Science ID A1983QH45800007

  View details for PubMedID 6831887

• PREDOMINANCE OF BRONCHOPULMONARY DYSPLASIA (BPD) IN INFANTS LESS-THAN-1500 GM AT BIRTH Smith, D. W., Stevenson, D. K., Sunshine, P., Northway, W., Ariagno, R. L. AMER THORACIC SOC. 1983: 212–12

  View details for Web of Science ID A1983QM03800591

• MISCONCEPTIONS ABOUT SLEEP PEDIATRICS Guilleminault, C., Ariagno, R., KOROBKIN, R., Coons, S. 1983; 72 (5): 752-753

  View details for Web of Science ID A1983RQ01700040

  View details for PubMedID 6634289

• TRANS-CUTANEOUS PO2 MONITORING IN INFANTS WITH CYANOTIC CONGENITAL HEART-DISEASE TREATED WITH PROSTAGLANDIN-E1 PEDIATRIC CARDIOLOGY KIMBLE, K. J., Ariagno, R. L., PITLICK, P. 1983; 4 (2): 87-89

  Abstract

  Transcutaneous PO2 (tcPO2) has been shown to closely approximate arterial PO2 (PaO2) in infants with normal oxygenation (PaO2 60-100 mm Hg). During hypoxemia (PaO2 less than 60 mm Hg), or administration of vasoactive drugs, such as tolazoline, correlation is frequently so poor that tcPO2 monitoring is of little value. We examined the relationship of tcPO2 to PaO2 among 6 infants with cyanotic congenital heart disease who were receiving prostaglandin E1 (PGE1). Close, linear correlation was found, even during hypoxemia. We conclude that tcPO2 monitoring has potential clinical value in such patients.

  View details for Web of Science ID A1983QY45100001

  View details for PubMedID 6878077

• SEQUELAE OF MATERNALLY DERIVED CYTOMEGALOVIRUS INFECTIONS IN PREMATURE-INFANTS JOURNAL OF PEDIATRICS YEAGER, A. S., Palumbo, P. E., MALACHOWSKI, N., Ariagno, R. L., Stevenson, D. K. 1983; 102 (6): 918-922

  Abstract

  Eighteen of 106 (17%) infants of seropositive mothers, with birth weights less than 1500 gm, acquired cytomegalovirus from a maternal source. Neutropenia, lymphocytosis, thrombocytopenia, and hepatosplenomegaly developed in some infants concomitant with the onset of CMV excretion. Infected infants who excreted CMV at less than 7 weeks of age had longer oxygen requirements than infants who did not excrete CMV until they were older. Passively derived maternal antibody to CMV fell more rapidly over the first few months of life in sick premature infants than would be expected in term infants. Among six infected premature infants, five had undetectable antibody titers when CMV excretion began. Loss of passively acquired antibody and early excretion of virus appear to be associated with symptomatic CMV infections in premature infants of seropositive mothers.

  View details for Web of Science ID A1983QU32100022

  View details for PubMedID 6304275

• DETECTION OF GASTRIC CONTENTS IN TRACHEAL FLUID OF INFANTS BY LACTOSE ASSAY JOURNAL OF PEDIATRICS Hopper, A. O., Kwong, L. K., Stevenson, D. K., SHAHIN, S. M., DHARLINGUE, A., TSUBOI, K. K., Ariagno, R. L. 1983; 102 (3): 415-418

  Abstract

  We designed an in vitro assay to detect the presence of lactose in the tracheal aspirates of premature, ventilator-dependent infants. This method was employed to identify recurrent, unrecognized aspiration, which could prolong the requirements for ventilator support and contribute to the development of chronic lung disease. One hundred five determinations of lactose were performed on the tracheal fluid obtained from 42 ventilator-dependent infants who were receiving enteral feedings. There was a wide range of lactose levels (0 to 3,270 nmol lactose/ml tracheal aspirate). Six infants had samples that were highly suggestive of aspiration (greater than 200 nmol lactose/ml tracheal aspirate). Twenty infants had questionably positive samples (25 to 200 nmol lactose/ml tracheal aspirate), and 16 infants had samples that were considered negative for aspiration (less than 25 nmol lactose/ml tracheal aspirate).

  View details for Web of Science ID A1983QF66500023

  View details for PubMedID 6402576

• NEAR-MISS FOR SUDDEN INFANT DEATH SYNDROME INFANTS - A CLINICAL PROBLEM PEDIATRICS Ariagno, R. L., Guilleminault, C., KOROBKIN, R., OWENBOEDDIKER, M., Baldwin, R. 1983; 71 (5): 726-730

  Abstract

  Three hundred six infants were referred for evaluation of "near-miss" sudden infant death syndrome (SIDS) from 1973 to 1980. Following the hospitalization and medical evaluation, there were 156 infants (115 term and 41 preterm) for whom there was no explanation for the presenting event and who were considered near-miss infants; 88% of these infants were seen during the first 3 months of life. A repeat near-miss event was reported in 63% (term) and 83% (preterm) infants. Twelve percent of term infants and 17% of the preterm infants had ten or more repeat events. A home apnea/cardiac monitor was prescribed for 88% of the infants for an average duration of 5.6 months in term infants and 3.5 months in preterm infants. Monitoring had been discontinued in 69% of the infants by 7 months of age. One full-term infant was later a SIDS victim. The risk of a repeat near-miss event is concluded to be sufficiently great to demand immediate hospitalization, medical evaluation, home monitoring when there is no specific treatment, and close clinical follow-up. Follow-up studies are needed to determine whether there is any long-term morbidity for infants who have had near miss events.

  View details for Web of Science ID A1983QP74400003

  View details for PubMedID 6835754

• MOVEMENT AND GASTRO-ESOPHAGEAL REFLUX IN AWAKE TERM INFANTS WITH NEAR MISS SIDS, UNRELATED TO APNEA JOURNAL OF PEDIATRICS Ariagno, R. L., Guilleminault, C., Baldwin, R., OWENBOEDDIKER, M. 1982; 100 (6): 894-897

  Abstract

  Forty-five term infants who had a "near miss" for SIDS were studied with a continuous overnight polygraphic recording of endoesophageal pH, respiration, and ECG. Recordings were examined for occurrences of GER and for central apnea of 10 seconds or greater duration. There were 341 apneic events greater than or equal to 10 seconds recorded in 46 studies, with a mean of 7 +/- 7. In 91% of the infants, no apneas exceeded 15 seconds. Only 31 episodes of apnea greater than or equal to 10 seconds occurred during GER: in two of these episodes the apneic event was greater than or equal to 15 seconds. Twenty-four of the 31 apneas greater than or equal to 10 seconds during periods of pH less than 4 occurred in one infant. A total of 356 precipitous pH drops was recorded (mean 8.7 +/- 7.4). The pH drops occurred most frequently when the patient appeared to be awake (73%), and in 84% of events there was movement before and during the pH change. We conclude that the majority of these near miss SIDS infants had GER associated with movement during awake periods, without any temporal relationship to apnea. Although reflex apnea following GER may be seen in some term infants, this problem may be more significant for the immature infant.

  View details for Web of Science ID A1982NT06400008

  View details for PubMedID 7086588

• GROWTH TO AGE 3 YEARS AMONG VERY LOW-BIRTH-WEIGHT SEQUELAE-FREE SURVIVORS OF MODERN NEONATAL INTENSIVE-CARE JOURNAL OF PEDIATRICS KIMBLE, K. J., Ariagno, R. L., Stevenson, D. K., Sunshine, P. 1982; 100 (4): 622-624

  View details for Web of Science ID A1982NK67300025

  View details for PubMedID 7062213

• THE EFFECT OF SLEEP STATE ON ACTIVE THERMOREGULATION IN THE PREMATURE-INFANT PEDIATRIC RESEARCH Darnall, R. A., Ariagno, R. L. 1982; 16 (7): 512-514

  Abstract

  Alterations in thermoregulatory mechanisms related to sleep state may play an important role in the problems of homeostasis experienced by the premature infant. In the adult, homeothermic regulation of body temperature may be suspended during REM. We measured oxygen consumption (VO2) in six premature infants 33-35 wk gestation both at thermoneutrality and during a mild thermal stress to determine whether thermoregulatory responses were intact during REM sleep. All infants were studied under radiant warmers. Skin temperature was allowed to fall 7-8 times during a 6-8 h study period while VO2, VCO2, heart rate and TcPO2 were continuously recorded. Sleep state was scored using EEG, EOG, EMG and behavioral criteria. A total of 1,162 one-min epochs were scored. In all states including REM, VO2 was significantly higher during the cool periods. The mean increases: 21.5%, 23.3%, 11.1% and 5.3% for Awake, Indeterminate, REM and NREM respectively. When REM and NREM were compared at thermoneutrality, there was no difference in the VO2 (8.80 +/- 0.11 and 8.93 +/- 0.15 cc/kg/min, mean +/- S.E., for REM and NREM, respectively). We conclude that in contrast to the adult, active thermoregulation occurs in the premature infant during REM sleep.

  View details for Web of Science ID A1982NV77200002

  View details for PubMedID 7110770

• CONGENITAL CENTRAL ALVEOLAR HYPOVENTILATION SYNDROME IN 6 INFANTS PEDIATRICS Guilleminault, C., MCQUITTY, J., Ariagno, R. L., Challamel, M. J., KOROBKIN, R., McClead, R. E. 1982; 70 (5): 684-694

  Abstract

  Six infants with congenital alveolar hypoventilation syndrome (CCHS) were seen and observed over several years. Two had an association of CCHS with Hirchsprung's disease. All infants were treated by tracheostomy and mechanical ventilation. Three infants have survived (including one with CCHS and Hirchsprung's disease). However, all survivors have required frequent rehospitalization. The infant with the longest survival (now 4 years of age) has developed significant daytime problems involving the "behavioral control" of ventilation. One infant was considered as a "near miss for sudden infant death syndrome" and became significantly symptomatic after establishment of delta (stage 3-4 non-rapid eye movement) sleep, which normally develops between 2 and 4 months of age. CCHS involves autonomic nervous system dysfunction, and the question of a defect involving the integration of chemoreceptor information more than a direct defect of the central chemoreceptor is discussed.

  View details for Web of Science ID A1982PQ19700004

  View details for PubMedID 7133818

• FAVORABLE RESULTS OF NEONATAL INTENSIVE-CARE FOR VERY LOW-BIRTH-WEIGHT INFANTS PEDIATRICS Cohen, R. S., Stevenson, D. K., MALACHOWSKI, N., Ariagno, R. L., KIMBLE, K. J., Hopper, A. O., Johnson, J. D., UELAND, K., Sunshine, P. 1982; 69 (5): 621-625

  Abstract

  From 1961 to 1976, 229 infants with birth weights ranging from 751 to 1,000 gm were admitted to the Stanford University Hospital Intensive Care Nursery. The overall neonatal mortality for these infants was 63% (144/229), and there were ten late deaths. Before 1967, no infant in this group who required mechanical ventilation survived; thereafter, 30% (34/114) of the ventilated patients survived. Of the 75 long-term survivors 60 participated in a high-risk infant follow-up program; these included 23 infants who had received mechanical ventilation. The mean birth weight of these infants was 928 +/- 67 (SD) gm. Seventeen children (28%) had significant morbidity: seven (12%) with severe handicaps and ten (17%) with moderate handicaps. During this same period, seven infants weighing less than 750 gm at birth were also observed. The three infants who had not required ventilatory support thrived; the other four infants had required respirators and were significantly handicapped. More recently, neonatal mortality for infants with birth weights from 751 to 1,000 gm has improved: for 1977 to 1980, it was 28% (33/118). Furthermore, neonatal mortality for ventilated infants in this weight group was 27% (26/95). These data indicate an improved prognosis for very low-birth-weight infants, even with ventilatory support.

  View details for Web of Science ID A1982NN58700022

  View details for PubMedID 7079021

• TRANS-CUTANEOUS OXYGEN MONITORING, HYPOXIC RANGE AND CORRELATION WITH PROSTAGLANDIN-E1 KIMBLE, K. J., Ariagno, R. L., Stevenson, D. K., Sunshine, P. SLACK INC. 1981: A142–A142

  View details for Web of Science ID A1981KY10800841

• DETECTION OF GASTRIC CONTENTS IN TRACHEAL FLUID OF PRETERM INFANTS Hopper, A. O., Kwong, L. K., Ariagno, R. L. NATURE PUBLISHING GROUP. 1981: 721–21

  View details for Web of Science ID A1981LG15501686

• TRANS-CUTANEOUS OXYGEN MONITORING, HYPOXIC RANGE AND CORRELATION WITH PROSTAGLANDIN-E1 KIMBLE, K. J., Ariagno, R. L., Stevenson, D. K., Sunshine, P. NATURE PUBLISHING GROUP. 1981: 666–66

  View details for Web of Science ID A1981LG15501359

• A DOUBLE-BLIND-STUDY OF THE EFFECTS OF ORAL INDOMETHACIN IN PRETERM INFANTS WITH PATENT DUCTUS-ARTERIOSUS WHO FAILED MEDICAL-MANAGEMENT PEDIATRIC PHARMACOLOGY Neu, J., Ariagno, R. L., Johnson, J. D., Pitlick, P. T., Cohen, R. S., BEETS, C. L., Sunshine, P. 1981; 1 (3): 245-249

  Abstract

  Over a two year period, 52 infants were found to have clinical signs of patent ductus arteriosus (PDA). Twenty-seven responded to fluid restriction and furosemide; the remaining 25 infants entered the Indomethacin (IN) study protocol. Their mean (+/- SE) gestational age was 29.3 (+/- 0.6) weeks and birth weight was 1,142 (+/- 80) gm. Either a placebo or IN (0.25 mg/kg) orally was given for two doses, 24 hours apart; if no response occurred, the patient was crossed over to the opposite medication. Using Chi-square analysis, a significant response rate to IN was found. There were no significant differences in birth weights, gestational ages, or fluid intake between responders and nonresponders. However, both responders and nonresponders required a prolonged ventilator course, suggesting factors other than PDA causing prolonged ventilatory requirements in these babies.

  View details for Web of Science ID A1981LQ63100009

  View details for PubMedID 7346744

• SLEEP PARAMETERS AND RESPIRATORY VARIABLES IN NEAR MISS SUDDEN INFANT DEATH SYNDROME INFANTS PEDIATRICS Guilleminault, C., Ariagno, R., KOROBKIN, R., Coons, S., OWENBOEDDIKER, M., Baldwin, R. 1981; 68 (3): 354-360

  Abstract

  Twenty-nine near miss for sudden infant death syndrome and thirty normal infants between the ages of 3 weeks and 6 months were monitored polygraphically for 24 hours. The distribution of sleep and abnormal respiratory events were analyzed for both groups. On the basis of mixed and obstructive apnea, 12-hour nocturnal segments (8 PM to 8 AM) consistently distinguished near miss from normal infant groups between the ages of 3 weeks and 4.5 months. Daytime naps do not provide statistical differences sufficient to differentiate between the two groups. During sleep, abnormal respiratory events are more likely to occur between 1 AM and 6 AM, at least 40 minutes after sleep onset. Respiratory pauses show a significant increase just prior to waking (a strong respiratory stimulus). Any impairment of the arousal threshold during sleep will place near miss infants at increased risk.

  View details for Web of Science ID A1981ME20700007

  View details for PubMedID 7279460

• A DOUBLE-BLIND-STUDY OF THE EFFECTS OF ORAL INDOMETHACIN (IN) IN PRETERM INFANTS WITH PATENT DUCTUS-ARTERIOSUS (PDA) WHO FAILED MEDICAL-MANAGEMENT Neu, J., Ariagno, R. L., Johnson, J. D., Pitlick, P. T., Cohen, R. S., BEETS, C. L., Sunshine, P. NATURE PUBLISHING GROUP. 1980: 607–

  View details for Web of Science ID A1980JL99401087

• LATE MORBIDITY AMONG SURVIVORS OF RESPIRATORY-FAILURE TREATED WITH TOLAZOLINE JOURNAL OF PEDIATRICS Cohen, R. S., Stevenson, D. K., MALACHOWSKI, N., Ariagno, R. L., Johnson, J. D., Sunshine, P. 1980; 97 (4): 644-647

  View details for Web of Science ID A1980KL58300030

  View details for PubMedID 6158564

• OUTCOME OF PRETERM INFANTS REQUIRING PROLONGED VENTILATORY SUPPORT KIMBLE, K. J., Ariagno, R. L., MALACHOWSKI, N., Sunshine, P. NATURE PUBLISHING GROUP. 1980: 601–

  View details for Web of Science ID A1980JL99401054

• WAKING AND VENTILATORY RESPONSES DURING SLEEP IN INFANTS NEAR-MISS FOR SUDDEN INFANT DEATH SYNDROME SLEEP Ariagno, R., Nagel, L., Guilleminault, C. 1980; 3 (3-4): 351-359

  View details for Web of Science ID A1980LA68900016

  View details for PubMedID 7221343

• MIXED AND OBSTRUCTIVE SLEEP APNEA AND NEAR MISS FOR SUDDEN INFANT DEATH SYNDROME .2. COMPARISON OF NEAR MISS AND NORMAL CONTROL INFANTS BY AGE PEDIATRICS Guilleminault, C., Ariagno, R., KOROBKIN, R., Nagel, L., Baldwin, R., Coons, S., Owen, M. 1979; 64 (6): 882-891

  Abstract

  Twenty-nine full-term near miss for sudden infant death syndrome (SIDS) and 30 normal control infants underwent 24-hour polygraphic monitoring. Several types of respiratory events during sleep (eg, central, mixed, and obstructive apnea, periodic breathing) were defined and tabulated. Analysis of these respiratory variables and comparison of groups of near miss and control infants indicated that between 3 weeks and 4 1/2 months of age only one variable was consistently different at a statistically significant level: the number of mixed and obstructive apnea greater than 3 seconds during total sleep time. This study also showed an increase in mixed and obstructive respiratory events during sleep at 6 weeks of age in control as well as in near miss infants.

  View details for Web of Science ID A1979HX49700009

  View details for PubMedID 229459

• MANAGEMENT OF POSTOPERATIVE DIAPHRAGMATIC PARALYSIS IN THE INFANT Watson, S. P., Maze, A., Hackel, A., Johnson, J. D., Ariagno, R. L., Sunshine, P. SLACK INC. 1979: A130–A130

  View details for Web of Science ID A1979GC72700764

• RESTING OXYGEN-CONSUMPTION OF PREMATURE-INFANTS COVERED WITH A PLASTIC THERMAL BLANKET PEDIATRICS Darnall, R. A., Ariagno, R. L. 1979; 63 (4): 547-551

  Abstract

  Premature infants in single-wall incubators covered with "thermal blankets" made of plastic packing material have large reductions in insensible water loss (IWL) compared with naked infants. We postulated that such reductions inevaporative heat loss would not result in decreases in caloric expenditure if body temperature were maintained by a servocontrolled heat source. Using an open-circuit technique, we measured oxygen consumption (VO2), carbon dioxide production (VCO2), heart rate (HR), respiratory rate (RR), and abdominal skin (Tabd), cheek, thigh, rectal, incubator air, wall, and room air temperatures in ten infants less than 37 weeks gestational age and from 2 to 24 days of age both naked and covered with a plastic thermal blanket. Tabd temperature was maintained between 36.2 and 36.8 C and rectal temperature between 36.8 and 37.2 C in each environment by manual or automatic servocontrol. A "resting state" was defined by using a combination of subjective and objective criteria. The mean values of VO2 during the "resting state" were 7.31 and 7.59 cc/kg of body weight per minute for naked and covered infants, respectively. There were no significant differences between mean values of VCO2, respiratory quotient, HR, RR, abdominal, cheek, thigh, or rectal temperatures in the two environments. Operant temperatures averaged 0.5 C lower when the infants were covered. These data support the hypothesis that decreases in insensible water loss do not necessarily imply reductions in caloric requirements in infants where Tabd is maintained by servocontrol.

  View details for Web of Science ID A1979GQ60600009

  View details for PubMedID 440864

• REFRACTORY HYPOXEMIA ASSOCIATED WITH NEONATAL PULMONARY-DISEASE - USE AND LIMITATIONS OF TOLAZOLINE JOURNAL OF PEDIATRICS Stevenson, D. K., KASTING, D. S., Darnall, R. A., Ariagno, R. L., Johnson, J. D., MALACHOWSKI, N., BEETS, C. L., Sunshine, P. 1979; 95 (4): 595-599

  Abstract

  Thirty-nine critically ill infants with pulmonary disease received tolazoline because of severe hypoxemia refractory to administration of 100% O2 and mechanical ventilation. Twenty-seven (69%) of the infants responded with an increase in PaO2 greater than or equal to 20 torr in the first umbilical arterial gas after completion of the initial ten-minute infusion (1 to 2 mg/kg) of the drug. A response was not correlated with survival. The overall survival was 46%, essentially unchanged from our previous report (44%). Infants with hyaline membrane disease had the poorest survival rate (33%). Complications associated with the use of tolazoline occurred in 82% of the infants. A hypotensive reaction, defined as a 25% decrease in mean arterial pressure from the pre-tolazoline level, occurred in 67% of the infants, and more commonly in the infants with RDS (87%). In 11 infants who did not respond to the initial dose of tolazoline, the dose was increased up to 10 mg/kg/hour; only one infant responded, and eight (73%) had a hypotensive reaction.

  View details for Web of Science ID A1979HN82900024

  View details for PubMedID 480041

• OBSTRUCTIVE SLEEP APNEA AND NEAR MISS FOR SIDS .1. REPORT OF AN INFANT WITH SUDDEN-DEATH PEDIATRICS Guilleminault, C., Ariagno, R. L., Forno, L. S., Nagel, L., Baldwin, R., Owen, M. 1979; 63 (6): 837-843

  Abstract

  An infant girl followed up from birth to death at the University Medical Center had "congenital stridor'' and a "near miss for SIDS'' event at 3 months of age. As part of an ongoing SIDS research project, she underwent 24-hour polygraphic monitoring at 21 weeks of age. Sudden infant death occurred within 30 hours after the polygraphic study. Polygraphic data obtained from this infant are compared with those from control infants and other infants with near miss for SIDS who were of similar ages. The number of mixed and obstructive respiratory events during sleep was abnormally high on the infant's recording. Histologic findings, involving particularly the midline structures of the brain stem, are discussed.

  View details for Web of Science ID A1979GX74100004

  View details for PubMedID 450518

• MINIMAL OXYGEN-CONSUMPTION IN INFANTS CARED FOR UNDER OVERHEAD RADIANT WARMERS COMPARED WITH CONVENTIONAL INCUBATORS JOURNAL OF PEDIATRICS Darnall, R. A., Ariagno, R. L. 1978; 93 (2): 283-287

  Abstract

  Infants under radiant warmers have large increases in insensible water loss compared with infants in single wall incubators. To answer the question of whether or not a minimal rate of oxygen consumption could be achieved under overhead radiant warmers, we measured oxygen consumption, carbon dioxide production, and abdominal skin, cheek, rectal, thigh, and environmental temperature in ten healthy newborn infants in incubators and radiant warmers, using each infant as his/her own control. The minimal VO2 ranged from 4.41 to 8.87 and from 4.35 to 9.06 cc/kg/minute in the incubator and radiant warmer, respectively. The differences were clearly not significant (paired Student t-test, P greater than 0.60). There were no significant differences between the respiratory quotients, VCO2, or abdominal skin, check, rectal or environmental temperatures. These data support the hypothesis that a thermoneutral environment can be provided with a radiant warmer and imply that large increases in insensible water loss can occur without affecting minimal oxygen consumption.

  View details for Web of Science ID A1978FJ17600034

  View details for PubMedID 678328

• USE OF TOLAZOLINE IN INFANTS WITH SEVERE HYPOXEMIA ASSOCIATED WITH PULMONARY-DISEASE KASTING, D. S., Darnall, R. A., Stevenson, D. K., Ariagno, R. L., Johnson, J. D., MALACHOWSKI, N., Sunshine, P. INT PEDIATRIC RESEARCH FOUNDATION, INC. 1978: 528–28

  View details for Web of Science ID A1978EV11700984

• WHY SHOULD WE STUDY INFANT NEAR MISS FOR SUDDEN INFANT DEATH EARLY HUMAN DEVELOPMENT Guilleminault, C., Ariagno, R. L. 1978; 2 (3): 207-218

  Abstract

  The use of 'near miss for Sudden Infant Death syndrome' infants as a model toward understanding the Sudden Infant Death syndrome has been questioned. Although there are numerous problems in delineating this patient population and defining events occurring during sleep, continuous polygraphic monitoring demonstrates potentially life-threatening events.

  View details for Web of Science ID A1978FT99100002

  View details for PubMedID 233214

• ABNORMAL POLYGRAPHIC FINDINGS IN NEAR-MISS SUDDEN INFANT DEATH LANCET Guilleminault, C., Ariagno, R., Souquet, M., Dement, W. C. 1976; 1 (7973): 1326-1327

  Abstract

  Sleep, respiratory, and cardiac data obtained during sleep and wakefulness by continuous 24-hour polygraphic monitoring from twelve infants who were "near misses" for the sudden-infant-death syndrome were compared with similar information obtained from seven low-risk infants. Although the sleep variables studied were of limited value in differentiating between the low and high risk patients, respiratory and cardiac abnormalities were strikingly more common in near-miss infants. High-risk infants demonstrated both obstructive and mixed stopped-breathing episodes (S.B.E.). Bradycardia was seen secondary to S.B.E. but also simultaneously with or independent of S.B.E. Sudden asystole associated with S.B.E. was seen in one case. These results suggest an autonomic-nervous-system dysfunction in high-risk infants.

  View details for Web of Science ID A1976BU66200010

  View details for PubMedID 58314